Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Pancreatic Cancer,2017,NCI,5F31CA203563-02,,Investigating the Role of Novel Drug Target TBK1 in Pancreatic Cancer Pathogenesis,"BRANNON, ARTHUR",UNIVERSITY OF MICHIGAN,MI,"$28,044"
Pancreatic Cancer,2017,NCI,5R01CA163489-05,,Characterization of lcmt in Animal Models of Cancer,"PHILIPS, MARK",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$351,713"
Pancreatic Cancer,2017,NIAID,5R01AI058072-12,,Structural Basis for Chemokine Function,"VOLKMAN, BRIAN",MEDICAL COLLEGE OF WISCONSIN,WI,"$344,250"
Pancreatic Cancer,2017,NCI,5R21CA202487-02,,KRAS Muations in Plasma cfDNA as Predictor to Erolinib Response in Advanced Pancreatic Cancer,"LI, DONGHUI",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$174,000"
Pancreatic Cancer,2017,NCI,5R01CA051210-25,,Biochemical and molecular studies on NQO1.  Design of less toxic Hsp90 inhibitors,"ROSS, DAVID",UNIVERSITY OF COLORADO DENVER,CO,"$312,983"
Pancreatic Cancer,2017,NCI,5R01CA201318-02,,The Paradoxical Role of mTORC1 in the Growth of Nutrient-deprived Pancreatic Cancer Cells Harboring Ras Mutations,"THOMPSON, CRAIG",SLOAN-KETTERING INST CAN RESEARCH,NY,"$339,879"
Pancreatic Cancer,2017,NCI,1R35CA210088-01,,The Role of Stem Cells and the Microenvironment in Gastrointestinal Cancers,"WANG, TIMOTHY",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$942,000"
Pancreatic Cancer,2017,NCI,5F31CA180738-04,,Genetic and pharmacological manipulation of system xc in pancreatic cancer,"BADGLEY, MICHAEL",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$44,044"
Pancreatic Cancer,2017,NCI,5R01CA200572-02,,PKD1 signaling in the initiation of pancreatic cancer,"STORZ, PETER",MAYO CLINIC  JACKSONVILLE,FL,"$357,994"
Pancreatic Cancer,2017,NCI,5R01CA193895-02,,Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy,"SLUSHER, BARBARA",JOHNS HOPKINS UNIVERSITY,MD,"$425,618"
Pancreatic Cancer,2017,NCI,5R01CA193365-02,,Molecular Imaging of Cachexia in Pancreatic Cancer,"BHUJWALLA, ZAVER",JOHNS HOPKINS UNIVERSITY,MD,"$370,575"
Pancreatic Cancer,2017,NCI,5R21CA194836-02,,Mouse model to study dependence of pancreatic cancer on Pik3ca for progression,"LIN, RICHARD",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$169,711"
Pancreatic Cancer,2017,NCI,5R01CA123031-09,,Dynamic requirements of Ras signaling during cancer,"COUNTER, CHRISTOPHER",DUKE UNIVERSITY,NC,"$341,999"
Pancreatic Cancer,2017,NCI,5R01CA168448-05,,Next Generation Oncolytic Adenovirus for Advanced Pancreatic Cancer Treatment,"YAMAMOTO, MASATO",UNIVERSITY OF MINNESOTA,MN,"$315,400"
Pancreatic Cancer,2017,NCI,5R01CA202846-02,,Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticles,"YANG, LILY",EMORY UNIVERSITY,GA,"$411,268"
Pancreatic Cancer,2017,NCI,5R01CA184510-03,,Genetic analysis of ras mutation specificity in skin and lung cancer,"BALMAIN, ALLAN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$362,512"
Pancreatic Cancer,2017,NCI,5R01CA172380-05,,Determining the Roles of ATRX and DAXX Abnormalities in Cancer Telomere Biology,"MEEKER, ALAN",JOHNS HOPKINS UNIVERSITY,MD,"$335,820"
Pancreatic Cancer,2017,NCI,5R01CA174861-04,,Novel Theranostics for Pancreatic Cancer,"DAVYDOVA, JULIA",UNIVERSITY OF MINNESOTA,MN,"$319,031"
Pancreatic Cancer,2017,NCI,5R01CA167291-05,,Novel Role of Ref-1 in Pancreatic Cancer Etiology and Progression,"KELLEY, MARK",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$493,963"
Pancreatic Cancer,2017,NCI,5R01CA183101-03,,Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy,"BACKMAN, VADIM",NORTHWESTERN UNIVERSITY,IL,"$634,023"
Pancreatic Cancer,2017,NCI,5R03CA201502-02,,Multiplex 'Conditional' Mice for Rapid and Affordable Pre-clinical Testing,"MORIARITY, BRANDEN",UNIVERSITY OF MINNESOTA,MN,"$76,208"
Pancreatic Cancer,2017,NCI,5R21CA185962-02,,Pancreatic Cyst Fluid miRNOME for Biomarkers of Pancreatic Cancer,"SEN, SUBRATA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$173,556"
Pancreatic Cancer,2017,NCI,5F32CA192904-03,,Finding Novel Pancreatic Cancer Oncogenes Using an Innovative 3D Culture System,"BAKER, LINDSEY",COLD SPRING HARBOR LABORATORY,NY,"$47,190"
Pancreatic Cancer,2017,NCI,5R01CA175772-04,,Targeting tumor-stromal interaction for pancreatic cancer therapy,"SINGH, AJAY",UNIVERSITY OF SOUTH ALABAMA,AL,"$314,363"
Pancreatic Cancer,2017,NCI,5F32CA180717-03,,The Characterization of the New Tumor Suppressor USP9X in Pancreatic Cancer,"HWANG, CHANG-IL",COLD SPRING HARBOR LABORATORY,NY,"$63,078"
Pancreatic Cancer,2017,NCI,5R01CA196215-02,,Systemic Therapy with Infectivity-Selective Oncolytic Adenovirus for PDAC,"YAMAMOTO, MASATO",UNIVERSITY OF MINNESOTA,MN,"$348,844"
Pancreatic Cancer,2017,NIAAA,5P50AA011999-19,8464,Animal Core,"TSUKAMOTO, HIDEKAZU",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$448,224"
Pancreatic Cancer,2017,NCI,5P01CA094237-15,7522,ENGINEERING T CELLS FOR PANCREATIC CANCER,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$254,484"
Pancreatic Cancer,2017,NCI,5F32CA200313-02,,K-Ras mutant-specific vulnerabilities for novel pancreatic cancer therapies,"HOBBS, GUY",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$57,066"
Pancreatic Cancer,2017,NCI,5R01CA172560-05,,Mechanisms of action of the Smyd3 methyltransferase in cancer cells,"GOZANI, OR",STANFORD UNIVERSITY,CA,"$457,506"
Pancreatic Cancer,2017,NCI,5R01CA181360-04,,Clustered semi-competing risks analysis in quality of end-of-life care studies,"HANEUSE, SEBASTIEN",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$446,179"
Pancreatic Cancer,2017,NCI,5F32CA192769-03,,MYC is a critical downstream effector in KRAS-driven pancreatic cancer,"ALLEN-PETERSEN, BRITTANY",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$60,990"
Pancreatic Cancer,2017,NCI,5R01CA183984-03,,A novel miR-198 replacement therapy for pancreatic cancer,"YAO, QIZHI",BAYLOR COLLEGE OF MEDICINE,TX,"$473,915"
Pancreatic Cancer,2017,NCI,5R01CA181450-04,,Pancreatic Ductal Adenocarcinoma is a disease of constitutive autophagy,"ZEH, HERBERT",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$319,550"
Pancreatic Cancer,2017,NCI,5R01CA135650-08,,Predictive Cancer Diagnostics and Therapy Response,"MOORE, ANNA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$552,368"
Pancreatic Cancer,2017,NCI,2P30CA006516-52,5410,Program 32: Gastrointestinal Malignancies,"FUCHS, CHARLES",DANA-FARBER CANCER INST,MA,"$42,984"
Pancreatic Cancer,2017,NCI,5R01CA192381-03,,Exploitation of RAS signaling to develop therapy and early detection strategies for PDA,"BREKKEN, ROLF",UT SOUTHWESTERN MEDICAL CENTER,TX,"$454,817"
Pancreatic Cancer,2017,NCI,1P01CA210944-01,5575,Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients,"VONDERHEIDE, ROBERT",UNIVERSITY OF PENNSYLVANIA,PA,"$654,726"
Pancreatic Cancer,2017,NCI,5R01CA186043-03,,Musashi-mediated control of pancreatic cancer growth and progression,"REYA, TANNISHTHA",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$379,518"
Pancreatic Cancer,2017,NCI,5R01CA203108-03,,Prognostic Biomarkers for ZIP4-mediated Cachexia in Pancreatic Cancer,"LI, MIN",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$539,228"
Pancreatic Cancer,2017,NCI,5R01CA175747-04,,"Mechanisms of PAK1 activation, signaling and tumor resistance","DER, CHANNING",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$406,839"
Pancreatic Cancer,2017,NCI,5P01CA084203-13,5335,"Core B: Biological Models, Biostatistics, Molecular Pathology and Microscopy","BOUMA, BRETT",MASSACHUSETTS GENERAL HOSPITAL,MA,"$159,779"
Pancreatic Cancer,2017,NCI,5P01CA084203-13,5338,Project 2: Endoscopic Photodynamic and Combination Therapy for Local and Metastatic Pancreatic Tumors,"PEREIRA, STEPHEN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$209,212"
Pancreatic Cancer,2017,NCI,5P01CA084203-13,5339,Project 3: Mechanism-Based Design ofCombination Therapies for Pancreatic Cancer,"HASAN, TAYYABA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$228,855"
Pancreatic Cancer,2017,NCI,5P01CA084203-13,5340,Project 4: Model-Based Dosimetry and Imaging for PDT,"POGUE, BRIAN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$167,050"
Pancreatic Cancer,2017,NCI,1R01CA211176-01,,Preclinical Analyses of NAD Kinase as a Redox Vulnerability for the Treatment of Pancreatic Cancer,"ELSEA, SARAH",BAYLOR COLLEGE OF MEDICINE,TX,"$362,569"
Pancreatic Cancer,2017,NCI,1R01CA211878-01,,Common genetically altered pathways as targets for therapy in pancreatic cancer,"WITKIEWICZ, AGNIESZKA",UNIVERSITY OF ARIZONA,AZ,"$351,131"
Pancreatic Cancer,2017,NCI,5R01CA172045-04,,Epigenetic regulation of pancreatic cancer,"HEBROK, MATTHIAS","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$328,888"
Pancreatic Cancer,2017,NCI,1R01CA211927-01,,Reconstituting human pancreatic cancer development for translational research,"KIM, SEUNG",STANFORD UNIVERSITY,CA,"$515,614"
Pancreatic Cancer,2017,NCI,1R01CA212350-01,,Stroma targeted theranostic nanoparticles for pancreatic cancer,"MCNALLY, LACEY",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$354,563"
Pancreatic Cancer,2017,NCI,1R01CA212600-01,,Targeting HuR to improve a synthetic lethal therapy for pancreatic cancer,"BRODY, JONATHAN",THOMAS JEFFERSON UNIVERSITY,PA,"$397,605"
Pancreatic Cancer,2017,NCI,5R01CA200755-02,,Exploring the Role of Mitochondrial Fission in Pancreatic Tumorigenesis,"KASHATUS, DAVID",UNIVERSITY OF VIRGINIA,VA,"$355,857"
Pancreatic Cancer,2017,NIGMS,5R01GM105964-04,,The molecular determinants of zinc uptake mediated by hZIP4,"DEMPSKI, ROBERT",WORCESTER POLYTECHNIC INSTITUTE,MA,"$285,769"
Pancreatic Cancer,2017,NCI,5R01CA189209-03,,Radio-immunotherapy to Target Cancer Stem Cells in Solid Tumor Malignancies,"MURPHY, WILLIAM",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$365,919"
Pancreatic Cancer,2017,NCI,5F30CA192819-03,,A differentiation-based mechanism limiting pancreatic tumor initiation,"KRAH, NATHAN",UNIVERSITY OF UTAH,UT,"$40,653"
Pancreatic Cancer,2017,NCI,1R03CA212068-01,,Epigenetic regulation of metabolic rerpogramming in pancreatic cancer,"TZATSOS, ALEXANDROS",GEORGE WASHINGTON UNIVERSITY,DC,"$79,750"
Pancreatic Cancer,2017,NCI,5R01CA131045-07,,ATDC Function in Human Pancreatic Adenocarcinoma,"SIMEONE, DIANE",UNIVERSITY OF MICHIGAN,MI,"$368,125"
Pancreatic Cancer,2017,NCI,5R01CA033084-34,,Mechanisms of Murine Turmor Eradication by Immunotherapy,"GREENBERG, PHILIP",UNIVERSITY OF WASHINGTON,WA,"$574,748"
Pancreatic Cancer,2017,NCI,5R01CA186662-04,,Novel Small Molecule MDM2 Inhibitors for Pancreatic Cancer Therapy,"ZHANG, RUIWEN",TEXAS TECH UNIVERSITY HEALTH SCIS CENTER,TX,"$480,479"
Pancreatic Cancer,2017,NCI,1R01CA213233-01,,Exosomes in Cancer Therapy,"KALLURI, RAGHU",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$384,147"
Pancreatic Cancer,2017,NIGMS,5P20GM109024-02,5952,Administrative Core: Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer,"MALLIK, SANKU",NORTH DAKOTA STATE UNIVERSITY,ND,"$643,945"
Pancreatic Cancer,2017,NIGMS,5P20GM109024-02,5953,Animal Core Facility,"GUO, BIN",NORTH DAKOTA STATE UNIVERSITY,ND,"$380,400"
Pancreatic Cancer,2017,NIGMS,5P20GM109024-02,5954,Nanoparticle-Powered Chemiluminescent Lateral Flow Biosensor Array for Early Diagnosis of Pancreatic Cancer,"LIU, GUODONG",NORTH DAKOTA STATE UNIVERSITY,ND,"$213,349"
Pancreatic Cancer,2017,NIGMS,5P20GM109024-02,5955,Effects of salinomycin and binding target proteins in pancreatic cancer,"WU, ERXI",NORTH DAKOTA STATE UNIVERSITY,ND,"$212,721"
Pancreatic Cancer,2017,NIGMS,5P20GM109024-02,5956,Combination Therapy: Targeting Pancreatic Cancer with a ROS Inducer and Gemcitabine,"REINDL, KATIE",NORTH DAKOTA STATE UNIVERSITY,ND,"$212,806"
Pancreatic Cancer,2017,NIGMS,5P20GM109024-02,5957,Development of Monoclonal Antibodies to Inhibit RAGE Activation in Pancreatic Cancer tumors,"LECLERC, ESTELLE",NORTH DAKOTA STATE UNIVERSITY,ND,"$212,747"
Pancreatic Cancer,2017,NCI,5U01CA175315-04,,MicroRNA-1291 in Regulation of Xenobiotic Disposition and Cell Differentiation,"YU, AIMING",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$310,326"
Pancreatic Cancer,2017,NIDDK,5R01DK055489-18,,Pancreas Transcription Factors and Disease Model Systems,"KONIECZNY, STEPHEN",PURDUE UNIVERSITY,IN,"$322,868"
Pancreatic Cancer,2017,NCI,1R21CA212827-01,,Single-molecule mechanical detection of protein and microRNA cancer biomarkers,"WONG, WESLEY",BOSTON CHILDREN'S HOSPITAL,MA,"$267,258"
Pancreatic Cancer,2017,NCI,5R01CA194593-03,,PQB3: Mechanisms & Targeting of Sonic Hedgehog Signaling in Muscle Wasting of Cancer Cachexia,"ZIMMERS, TERESA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$355,258"
Pancreatic Cancer,2017,NIAID,5R21AI124687-02,,Stromal IL-6/Jak-STAT signaling and pancreatitis,"OSTROWSKI, MICHAEL",OHIO STATE UNIVERSITY,OH,"$192,500"
Pancreatic Cancer,2017,NCI,5R01CA168611-05,,Toll-like Receptor Regulation of Pancreatic Tumorigenesis,"MILLER, GEORGE",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$351,713"
Pancreatic Cancer,2017,NCI,5R01CA178856-04,,Menin-mediated epigenetic tumor suppression,"HUA, XIANXIN",UNIVERSITY OF PENNSYLVANIA,PA,"$332,000"
Pancreatic Cancer,2017,NCI,5R01CA177670-04,,REPROGRAMMING THE METASTATIC MICROENVIRONMENT OF PANCREATIC CANCER THROUGH CSF1R,"DENARDO, DAVID",WASHINGTON UNIVERSITY,MO,"$316,438"
Pancreatic Cancer,2017,NCI,2R01CA157490-07A1,,Investigating the Role of Autophagy in Pancreatic Cancer Radiation Resistance,"KIMMELMAN, ALEC",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$402,563"
Pancreatic Cancer,2017,NCI,5F30CA203238-02,,Mechanisms of Escape from TGFÎ² Tumor Suppression in the Pancreas,"HUANG, YUN-HAN",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$49,044"
Pancreatic Cancer,2017,NCI,5R01CA203890-02,,COMBINED TUMOR AND STROMAL TARGETING TO IMPROVE PANCREATIC CANCER RESPONSE TO IMMUNOTHERAPY,"DENARDO, DAVID",WASHINGTON UNIVERSITY,MO,"$348,844"
Pancreatic Cancer,2017,NCI,1R01CA206105-01A1,,Regulation of Pancreatic Oncogenesis by the Gut Microbiome,"MILLER, GEORGE",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$375,150"
Pancreatic Cancer,2017,NCI,5F30CA196124-03,,Pro- and anti-phagocytic signals on pancreatic cancer regulate tumor macrophages,"LIU, MINGEN",UNIVERSITY OF PENNSYLVANIA,PA,"$30,917"
Pancreatic Cancer,2017,NCI,2R01CA163764-06,,On the path to the clinic: Lead optimization and pathway analysis of the pancreatic cancer-selective drug conjugate SW V-49,"HAWKINS, WILLIAM",WASHINGTON UNIVERSITY,MO,"$381,250"
Pancreatic Cancer,2017,NCI,1R01CA188134-01A1,,Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response,"TUVESON, DAVID",COLD SPRING HARBOR LABORATORY,NY,"$510,684"
Pancreatic Cancer,2017,NCI,1R01CA204969-01A1,,Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism,"NAGRATH, DEEPAK",UNIVERSITY OF MICHIGAN,MI,"$332,357"
Pancreatic Cancer,2017,NCI,1R01CA204916-01A1,,"Beyond apoptosis, Bcl-xL in tumor metastasis","DU, YI-CHIEH NANCY",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$406,557"
Pancreatic Cancer,2017,NCI,5R35CA197709-02,,New Ways of Targeting K-Ras,"MCCORMICK, FRANK","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$918,748"
Pancreatic Cancer,2017,NCI,5R01CA184051-03,,Pharmacological Ascorbate as a Radiosensitizer in Pancreatic Cancer,"CULLEN, JOSEPH",UNIVERSITY OF IOWA,IA,"$348,844"
Pancreatic Cancer,2017,NCI,5K07CA204201-02,,Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer,"ENZINGER, ANDREA",DANA-FARBER CANCER INST,MA,"$176,231"
Pancreatic Cancer,2017,NCI,1R01CA213278-01,,Reprogramming Tumor Microenvironment by Nanoparticle,"MUKHERJEE, PRIYABRATA",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$338,550"
Pancreatic Cancer,2017,NIDDK,1K08DK109492-01A1,,The role of progenitor cells in pancreatic acinar renewal and pre-malignant progression,"MADDIPATI, RAVIKANTH",UNIVERSITY OF PENNSYLVANIA,PA,"$170,196"
Pancreatic Cancer,2017,NCI,5R01CA188300-03,,Motion Management of Pancreatic Cancer in MRI-Guided Radiotherapy,"SHENG, KE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$337,028"
Pancreatic Cancer,2017,NCI,5R01CA154823-06,,Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (Study),"KLEIN, ALISON",JOHNS HOPKINS UNIVERSITY,MD,"$646,350"
Pancreatic Cancer,2017,NCI,5R01CA197916-02,,Targeting macrophages for immunotherapy in pancreatic cancer,"BEATTY, GREGORY",UNIVERSITY OF PENNSYLVANIA,PA,"$368,288"
Pancreatic Cancer,2017,NIDDK,5R01DK061220-13,,Transcriptional Regulators of the Exocrine Pancreatic Phenotype,"MACDONALD, RAYMOND",UT SOUTHWESTERN MEDICAL CENTER,TX,"$473,738"
Pancreatic Cancer,2017,NCI,2R01CA150190-06A1,,Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside,"MUKHOPADHYAY, DEBABRATA",MAYO CLINIC  JACKSONVILLE,FL,"$598,146"
Pancreatic Cancer,2017,NHGRI,1UM1HG009426-01,,Center for Functional Validation and Evaluation of ENCODE Enhancer Regions,"WHITE, KEVIN",UNIVERSITY OF CHICAGO,IL,"$654,000"
Pancreatic Cancer,2017,NCI,5F30CA196040-02,,Structural basis of chemokine receptor signaling in tumor progression,"KLEIST, ANDREW",MEDICAL COLLEGE OF WISCONSIN,WI,"$46,044"
Pancreatic Cancer,2017,NCI,5R01CA190717-03,,Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer,"BOGDANOV, VLADIMIR",UNIVERSITY OF CINCINNATI,OH,"$276,298"
Pancreatic Cancer,2017,NCI,5R01CA196941-02,,Novel Signaling Pathways Regulating Pancreatic Cancer Pathogenesis,"WANG, HUAMIN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$366,000"
Pancreatic Cancer,2017,NCI,5R01CA167535-05,,Novel Nanoparticle Therapy for Pancreatic Cancer,"MATTERS, GAIL",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$313,134"
Pancreatic Cancer,2017,NCI,5R01CA186286-04,,Pancreatic Cancer Cell Mechanics and Imaging,"KONSTANTOPOULOS, KONSTANTINOS",JOHNS HOPKINS UNIVERSITY,MD,"$426,010"
Pancreatic Cancer,2017,NCI,5F30CA200240-02,,Role of Nix in pancreatic ductal adenocarcinoma,"ALAGESAN, BRINDA",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$49,044"
Pancreatic Cancer,2017,NCI,5R01CA097022-15,,Survival Mechanisms of Invasive Carcinoma Cells,"KLEMKE, RICHARD",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$351,599"
Pancreatic Cancer,2017,NCI,5R01CA154649-07,,The role of entosis in human cancers,"OVERHOLTZER, MICHAEL",SLOAN-KETTERING INST CAN RESEARCH,NY,"$397,329"
Pancreatic Cancer,2017,NCI,5R01CA178445-03,,The role of wild-type KRAS in the context of tumor profession and metastasis,"SU, GLORIA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$462,118"
Pancreatic Cancer,2017,NCI,5R01CA198128-02,,Exploiting Caveolae-Dependent Albumin Endocytosis to Optimize Therapy in Pancreatic Cancer,"WILLIAMS, TERENCE",OHIO STATE UNIVERSITY,OH,"$397,192"
Pancreatic Cancer,2017,NCI,5R01CA172233-05,,Molecular Mediators of Pancreatic Cancer Invasion and Progression,"XIE, KEPING",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$332,000"
Pancreatic Cancer,2017,NCI,5R01CA187923-03,,Novel Strategies to Potentiate a Ras-targeted Oncolytic Herpes Simplex Virus,"ZHANG, XIAOLIU",UNIVERSITY OF HOUSTON,TX,"$344,023"
Pancreatic Cancer,2017,NCI,5R01CA075059-19,,Dysregulation of TGF Beta Action Pancreatic Cancer,"KORC, MURRAY",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$441,940"
Pancreatic Cancer,2017,NCI,5R01CA194941-02,,Suppression of pancreatic tumorigenesis by the PTF1 transcription factor network,"MURTAUGH, LEWIS",UNIVERSITY OF UTAH,UT,"$320,718"
Pancreatic Cancer,2017,NCI,5U01CA152653-07,,Detection and prognosis of early-stage pancreatic cancer by interdependent plasma markers,"HAAB, BRIAN",VAN ANDEL RESEARCH INSTITUTE,MI,"$554,248"
Pancreatic Cancer,2017,NCI,5R01CA180949-04,,Early detection of pancreatic cancer in diabetics,"CHEN, RU",UNIVERSITY OF WASHINGTON,WA,"$587,611"
Pancreatic Cancer,2017,NCI,5P30CA086862-17,7670,Program 1: Cancer Genes and Pathways,"QUELLE, DAWN",UNIVERSITY OF IOWA,IA,"$16,730"
Pancreatic Cancer,2017,NIDDK,5R01DK107767-02,,Omega-3 derived epoxy fatty acids and sEH in pancreatitis-induced carcinogenesis,"YANG, GUANG-YU",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$481,828"
Pancreatic Cancer,2017,NIGMS,5R01GM113166-03,,Polymeric Nanomedicines of Hedgehog Inhibitor and miRNA for Treating Pancreatic Cancer,"MAHATO, RAM",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$356,087"
Pancreatic Cancer,2017,NCI,1F32CA213764-01,,The role of neuroendocrine transdifferentiation of pancreatic cancer cells on tumor progression and chemoresistance.,"MORRISON JOLY, MEGHAN",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$56,694"
Pancreatic Cancer,2017,NCI,5R01CA185357-04,,(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer,"AHUJA, NITA",JOHNS HOPKINS UNIVERSITY,MD,"$398,393"
Pancreatic Cancer,2017,NCI,1F32CA213810-01,,Understanding metabolic pathways that support redox homeostasis in cancer,"MUIR, ALEXANDER",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$56,694"
Pancreatic Cancer,2017,NCI,1F30CA213883-01,,Identifying novel effectors of oncogenic Kras in pancreatic cells via proximity labelling,"CHENG, DEREK",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$33,839"
Pancreatic Cancer,2017,NCI,1F30CA213916-01,,FOLFOX-induced kinome reprogramming in pancreatic cancer tumor xenografts,"LIPNER, MATTHEW",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$30,078"
Pancreatic Cancer,2017,NCI,1R01CA208272-01A1,,Developing novel combination therapies for pancreatic cancer,"YOON, KARINA",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$339,694"
Pancreatic Cancer,2017,NCI,5F32CA200078-02,,Chemical genetic investigation of metastatic seeding in pancreatic ductal adenocarcinoma using novel multiplexed in vivo screening,"SCHULZE, CHRISTOPHER",STANFORD UNIVERSITY,CA,"$4,565"
Pancreatic Cancer,2017,NCI,5R01CA196228-03,,The Role of post-translational activation of Myc in pancreatic cancer,"SEARS, ROSALIE",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$390,191"
Pancreatic Cancer,2017,NCI,1R01CA202917-01A1,,JAK1 Signaling in Pancreatic Cancer Initiation and Progression,"WAGNER, KAY-UWE",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$340,193"
Pancreatic Cancer,2017,NCI,5R01CA184926-04,,(PQB-3) Driver gene-induced inflammation in pancreatic cancer development,"JAFFEE, ELIZABETH",JOHNS HOPKINS UNIVERSITY,MD,"$765,544"
Pancreatic Cancer,2017,NCI,5R01CA034610-35,,TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression,"MASSAGUE, JOAN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$468,594"
Pancreatic Cancer,2017,NCI,5R01CA169281-05,,Targeting Stromal Collagen in Pancreatic Cancer,"HAN, HAIYONG",TRANSLATIONAL GENOMICS RESEARCH INST,AZ,"$386,727"
Pancreatic Cancer,2017,NCI,5R01CA179645-04,,Mechanisms and targeting of SWI/SNF alterations in pancreatic cancer,"POLLACK, JONATHAN",STANFORD UNIVERSITY,CA,"$333,139"
Pancreatic Cancer,2017,NCI,1R01CA210439-01A1,,Targeting the Metabolic Basis of Cachexia in Pancreatic Cancer,"SINGH, PANKAJ",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$454,065"
Pancreatic Cancer,2017,NCI,5F32CA206234-02,,Exploring BCL-XL addiction in pancreatic ductal adenocarcinoma,"SODERQUIST, RYAN",DUKE UNIVERSITY,NC,"$57,066"
Pancreatic Cancer,2017,NCI,5R44CA203052-02,,LASER TISSUE WELDING: BREACHING BARRIERS IN THE SURGICAL MANAGEMENT OF THE PANCREAS,"WADIA, YASMIN","LASER TISSUE WELDING, INC.",TX,"$500,000"
Pancreatic Cancer,2017,NCI,5R01CA172431-05,,Inhibition of pancreatic carcinogenesis via targeting c-Raf and sEH,"YANG, GUANG-YU",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$320,338"
Pancreatic Cancer,2017,NCI,5R01CA196286-03,,Validation of pancreatic cancer biomarkers in large prospective cohorts,"LOKSHIN, ANNA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$417,779"
Pancreatic Cancer,2017,NCI,5R01CA176828-05,,Using Markers to Improve Pancreatic Cancer Screening,"GOGGINS, MICHAEL",JOHNS HOPKINS UNIVERSITY,MD,"$416,661"
Pancreatic Cancer,2017,NCI,5R01CA206444-02,,Rac1 GTPase in tumorigenesis and progression of pancreatic cancer,"OUELLETTE, MICHEL",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$374,745"
Pancreatic Cancer,2017,NCI,5R01CA198090-02,,Integrated Signaling in Pancreatic Cancer Progression,"XIE, KEPING",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$366,000"
Pancreatic Cancer,2017,NCI,5R01CA169702-05,,Annexin A2 as a mediator of pancreatic cancer metastases,"ZHENG, LEI",JOHNS HOPKINS UNIVERSITY,MD,"$336,150"
Pancreatic Cancer,2017,NCI,5R01CA204228-02,,Comprehensive genetic dissection of druggable KRAS targets,"LEACH, STEVEN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$392,078"
Pancreatic Cancer,2017,NCI,5F31CA206416-02,,Stem cell signals in pancreatic adenocarcinoma metastasis and therapy resistance,"LYTLE, NIKKI",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$37,905"
Pancreatic Cancer,2017,NCI,5U01CA200468-02,,A Clinical Validation Center for Early Detection of Pancreatic Cancer,"MAITRA, ANIRBAN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$1,759,344"
Pancreatic Cancer,2017,NCI,5R01CA193887-02,,Targeting extracellular matrix-cancer stem cell interactions in pancreatic cancer,"MATSUI, WILLIAM",JOHNS HOPKINS UNIVERSITY,MD,"$370,575"
Pancreatic Cancer,2017,NCI,5R01CA082683-18,,Signal Transduction by Tyrosine Phosphorylation,"HUNTER, TONY",SALK INSTITUTE FOR BIOLOGICAL STUDIES,CA,"$674,327"
Pancreatic Cancer,2017,NCI,5R01CA197999-02,,Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers,"NATARAJAN, AMARNATH",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$344,094"
Pancreatic Cancer,2017,NCI,5R01CA187090-04,,The Yap-Tead transcriptional complex in Kras-induced Pancreatic Ductal Adenocarci,"YI, CHUNLING",GEORGETOWN UNIVERSITY,DC,"$322,663"
Pancreatic Cancer,2017,NCI,5F30CA196087-02,,TSPO-PET to Image Pancreatic Cancer and High-Risk Precursor Lesions,"WATCHMAKER, JENNIFER",VANDERBILT UNIVERSITY,TN,"$44,044"
Pancreatic Cancer,2017,NCI,5R01CA182869-03,,The role of DCLK1 in the initiation of pancreatic ductal adenocarcinoma,"HOUCHEN, COURTNEY",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$345,918"
Pancreatic Cancer,2017,NCI,5R01CA168863-05,,CCR2 BLOCKADE IN HUMAN PANCREATIC CANCER,"LINEHAN, DAVID",UNIVERSITY OF ROCHESTER,NY,"$319,377"
Pancreatic Cancer,2017,OD,1S10OD023659-01,,Mass Spectrometer For Small Molecule Analysis,"NEUBERT, THOMAS",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$595,890"
Pancreatic Cancer,2017,NCI,5F31CA206233-02,,High-Throughput Generation of Pancreatic Organoids with Controlled Stromal Milieus using Microraft-Based Cell Sorting,"DISALVO, MATTHEW",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$34,866"
Pancreatic Cancer,2017,NCI,5U01CA200466-02,,Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms,"BRAND, RANDALL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$1,537,769"
Pancreatic Cancer,2017,NIDDK,7R01DK052913-18,,The Role of Zinc Finger Cofactors in Pancreatic Cell Growth,"URRUTIA, RAUL",MEDICAL COLLEGE OF WISCONSIN,WI,"$346,500"
Pancreatic Cancer,2017,NCI,5F30CA206240-02,,Mechanisms of Pancreatic Carcinogenesis,"HE, PING",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$31,678"
Pancreatic Cancer,2017,NCI,5R01CA124586-10,,Kras-Induced Cellular Plasticity in Pancreatic Cancer,"KONIECZNY, STEPHEN",PURDUE UNIVERSITY,IN,"$312,367"
Pancreatic Cancer,2017,NCI,5R01CA169086-05,,"PDG Links Stem Cell Niche to Pancreatic Epithelial Renewal, Repair and Cancer","THAYER, SARAH",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$312,288"
Pancreatic Cancer,2017,NCI,5F30CA189793-04,,Design and Development of a Small Molecule-controlled Activator of RAS,"ROSE, JOHN",UNIVERSITY OF WASHINGTON,WA,"$43,144"
Pancreatic Cancer,2017,NCI,5P01CA067166-20,7501,The Role of Ire1 in Modulating the Response of Tumors to Hypoxia and Radiation,"KOONG, ALBERT",STANFORD UNIVERSITY,CA,"$204,282"
Pancreatic Cancer,2017,NCI,1R33CA206907-01A1,,Rapid unbiased isolation and in situ RNA analysis of circulating tumor cells using a magnetic micropore-based diagnostic chip,"ISSADORE, DAVID",UNIVERSITY OF PENNSYLVANIA,PA,"$381,612"
Pancreatic Cancer,2017,NCI,1U01CA210020-01A1,,Molecular Imaging Methods for the Detection of Pancreatic Ductal Adenocarcinoma,"WILLMANN, JUERGEN",STANFORD UNIVERSITY,CA,"$603,260"
Pancreatic Cancer,2017,NCI,1U01CA214254-01,,Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer,"GOEL, AJAY",BAYLOR RESEARCH INSTITUTE,TX,"$1,075,356"
Pancreatic Cancer,2017,NCI,5R01CA207189-02,,Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma,"COMMISSO, COSIMO",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$446,063"
Pancreatic Cancer,2017,NCI,1U01CA210240-01A1,,Pancreatic Cancer Detection Consortium,"HOLLINGSWORTH, MICHAEL",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$1,761,905"
Pancreatic Cancer,2017,NCI,1R33CA204704-01A1,,Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells,"WANG, YINGXIAO",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$376,821"
Pancreatic Cancer,2017,NCI,5U01CA178960-04,,"Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis","DWINELL, MICHAEL",MEDICAL COLLEGE OF WISCONSIN,WI,"$515,751"
Pancreatic Cancer,2017,NCI,5K12CA090628-17,,Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic,"JATOI, AMINAH",MAYO CLINIC ROCHESTER,MN,"$810,000"
Pancreatic Cancer,2017,NCI,5R01CA198095-02,,Novel Strategies for Precision T-cell Therapies,"ALMO, STEVEN","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$520,564"
Pancreatic Cancer,2017,NCI,5P30CA056036-18,7226,Gastrointestinal Cancer,"KNUDSEN, KAREN",THOMAS JEFFERSON UNIVERSITY,PA,"$38,251"
Pancreatic Cancer,2017,NCI,5R01CA054358-24,,Epigenetic Drivers of Cancer Progression,"FEINBERG, ANDREW",JOHNS HOPKINS UNIVERSITY,MD,"$422,743"
Pancreatic Cancer,2017,NCI,5F30CA200301-03,,Mechanistic and Informatics Based Analysis of STAT1 Actions in Pancreatic Cancer,"CRAVEN, KELLY",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$48,053"
Pancreatic Cancer,2017,NCI,5R01CA136526-08,,Mechanism of Pancreatic Carcinogenesis,"FERNANDEZ-ZAPICO, MARTIN",MAYO CLINIC ROCHESTER,MN,"$344,108"
Pancreatic Cancer,2017,NCI,5F32CA200278-03,,Novel BPTES Analogs for the Treatment of Pancreatic Cancer,"ZIMMERMANN, SARAH",JOHNS HOPKINS UNIVERSITY,MD,"$12,629"
Pancreatic Cancer,2017,NHGRI,5F31HG008912-02,,Computational Modeling of Heterogeneous Gene Expression in Single Cells,"WELCH, JOSHUA",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$33,727"
Pancreatic Cancer,2017,NCI,5R01CA188252-03,,ROS-targeted therapy for pancreatic cancer,"NEAMATI, NOURI",UNIVERSITY OF MICHIGAN,MI,"$562,471"
Pancreatic Cancer,2017,NCI,5F32CA196120-03,,A cell-based liquid biopsy approach for early pancreatic cancer detection,"BHAGWAT, NEHA",UNIVERSITY OF PENNSYLVANIA,PA,"$57,066"
Pancreatic Cancer,2017,NCI,1R01CA215607-01,,Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer,"OLIVE, KENNETH",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$404,558"
Pancreatic Cancer,2017,NCI,5R21CA202745-02,,Dim light at night alters pancreatic cell signaling and predisposes to pancreatic adenocarcinoma,"NELSON, RANDY",OHIO STATE UNIVERSITY,OH,"$167,475"
Pancreatic Cancer,2017,NIDDK,5R01DK106266-04,,"Development, cellular plasticity and homeostasis of the exocrine pancreas","SOSA-PINEDA, BEATRIZ",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$336,725"
Pancreatic Cancer,2017,NCI,1U24CA209996-01A1,,Building protected data sharing networks to advance cancer risk assessment and treatment,"FOSTER, IAN",UNIVERSITY OF CHICAGO,IL,"$805,856"
Pancreatic Cancer,2017,NCI,5R01CA191191-03,,IDO2 Targeting in Pancreatic Cancer,"PRENDERGAST, GEORGE",LANKENAU INSTITUTE FOR MEDICAL RESEARCH,PA,"$391,418"
Pancreatic Cancer,2017,NCI,1R21CA215860-01,,CEST MRI assessment of tumor vascular permeability using non-labeled dextrans,"LIU, GUANSHU",HUGO W. MOSER RES INST KENNEDY KRIEGER,MD,"$175,782"
Pancreatic Cancer,2017,NIBIB,5R01EB017853-04,,Polymeric Nanomedicines of Small Molecules and miRNA for Treating Pancreatic Canc,"MAHATO, RAM",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$338,594"
Pancreatic Cancer,2017,NCI,1R01CA209798-01A1,,Investigating the cause of racial/ethnic disparity in pancreatic cancer incidence,"SETIAWAN, VERONICA",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$395,145"
Pancreatic Cancer,2017,NCI,5R01CA174294-05,,Multifunctional immunoPET tracers for pancreatic and prostate cancer,"WU, ANNA",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$444,176"
Pancreatic Cancer,2017,NCI,5R01CA186338-03,,ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer,"LI, MIN",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$342,938"
Pancreatic Cancer,2017,NCI,5R21CA198265-02,,New HuR inhibitor against pancreatic cancer EMT and CSCs,"CHEN, QI",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$166,388"
Pancreatic Cancer,2017,NCI,2R01CA154451-04A1,,Ultrasound-enhanced drug penetration for treatment of pancreatic cancer,"HWANG, JOO",UNIVERSITY OF WASHINGTON,WA,"$498,703"
Pancreatic Cancer,2017,NIBIB,1R01EB022230-01A1,,Image-Guided Drug Delivery for Pancreatic Neuroendocrine Tumor.,"CHOI, HAK SOO",MASSACHUSETTS GENERAL HOSPITAL,MA,"$676,225"
Pancreatic Cancer,2017,NCI,5R01CA124723-10,,The Inhibition of HSP70 Induces Apoptosis in Pancreatic Cancer Cells,"SALUJA, ASHOK",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$282,901"
Pancreatic Cancer,2017,NCI,5R01CA177857-05,,Role of Neurogenic Inflammation in Pancreatic Cancer,"DAVIS, BRIAN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$418,087"
Pancreatic Cancer,2017,NCI,5R01CA210553-02,,Image-guided ultrasound therapy and drug delivery in pancreatic cancer,"FERRARA, KATHERINE",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$636,467"
Pancreatic Cancer,2017,NIBIB,5R21EB022770-02,,High Sensitivity Molecular Ultrasound Imaging in Pancreatic Cancer,"WILLMANN, JUERGEN",STANFORD UNIVERSITY,CA,"$200,802"
Pancreatic Cancer,2017,NCI,1R21CA205094-01A1,,Primers: Combining Radiotherapy and Immunotherapy using next genertaion radiotherapy biomaterials,"NGWA, WILFRED",DANA-FARBER CANCER INST,MA,"$229,187"
Pancreatic Cancer,2017,NCI,5R01CA210192-02,,Targeted Nanotherapy for Pancreatic Cancer,"CHAUHAN, SUBHASH",UNIVERSITY OF TENNESSEE HEALTH SCI CTR,TN,"$347,700"
Pancreatic Cancer,2017,NCI,5R01CA184274-04,,Functional Significance of CD133 in Pancreatic Cancer,"BANERJEE, SULAGNA",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$318,513"
Pancreatic Cancer,2017,NCI,5R01CA194321-02,,Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer,"HUMM, JOHN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$660,603"
Pancreatic Cancer,2017,NCI,5R01CA172152-06,,Role of the SWI/SNF complex in tumor suppression,"ROBERTS, CHARLES",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$357,826"
Pancreatic Cancer,2017,NCI,5R01CA201226-02,,High Throughput Screening to Discover Chemical Inhibitors of Quiescin Sulfhydryl Oxidase 1,"FAIGEL, DOUGLAS",MAYO CLINIC ARIZONA,AZ,"$678,423"
Pancreatic Cancer,2017,NCI,1R21CA206013-01A1,,(PQ1) Cellular senescence as an initiating event in malignant transformation,"DAVID, GREGORY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$203,400"
Pancreatic Cancer,2017,NIGMS,2R15GM110632-02,,"Label-Free Nanopore Biosensor for Rapid, Ultrasensitive, and Multiplex Detection of Protease Activities","GUAN, XIYUN",ILLINOIS INSTITUTE OF TECHNOLOGY,IL,"$422,520"
Pancreatic Cancer,2017,NCI,5R01CA195586-03,,Targeted Radiation Therapy for Pancreatic Cancer,"BATRA, SURINDER",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$435,945"
Pancreatic Cancer,2017,NCI,5R01CA197296-03,,Reprogramming the pancreatic tumor microenvironment with immunotherapy,"ZHENG, LEI",JOHNS HOPKINS UNIVERSITY,MD,"$429,841"
Pancreatic Cancer,2017,NCI,3R01HD065800-07S1,,Mechanisms Controlling Epithelial Homeostasis,"O'REILLY, ALANA",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$214,199"
Pancreatic Cancer,2017,NICHD,3R01HD065800-07S1,,Mechanisms Controlling Epithelial Homeostasis,"O'REILLY, ALANA",RESEARCH INST OF FOX CHASE CAN CTR,PA,$1
Pancreatic Cancer,2017,NCI,5R01CA182311-04,,High dose radiation therapy to direct immune responses to pancreatic cancer,"GOUGH, MICHAEL",PROVIDENCE PORTLAND MEDICAL CENTER,OR,"$321,625"
Pancreatic Cancer,2017,NCI,5K08CA208016-02,,Elucidating KRAS-specific vulnerabilities in pancreatic cancer,"MUZUMDAR, MANDAR",DANA-FARBER CANCER INST,MA,"$37,557"
Pancreatic Cancer,2017,NCI,5R01CA208514-02,,Mechanisms of durable antitumor immunity via CD26hiCD4+ T cells,"PAULOS, CHRYSTAL",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$345,257"
Pancreatic Cancer,2017,NCI,1R01CA207236-01A1,,Fasting Protects Small Intestinal Stem Cells from Lethal DNA Damage: Mechanistic Insight and Preclinical Translation,"PIWNICA-WORMS, HELEN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$482,853"
Pancreatic Cancer,2017,NCI,5R01CA181385-04,,Stellate cells and their progenitor precursors in pancreas cancer progression,"PROVENZANO, PAOLO",UNIVERSITY OF MINNESOTA,MN,"$308,990"
Pancreatic Cancer,2017,NCI,5K99CA204725-02,,Exploring Glycobiology and Discovering Biomarkers for Pancreatic Cancer,"ENGLE, DANNIELLE",COLD SPRING HARBOR LABORATORY,NY,"$128,235"
Pancreatic Cancer,2017,NCI,5R01CA181244-04,,Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing,"SCHEET, PAUL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$1,028,501"
Pancreatic Cancer,2017,NCI,5R03CA208510-02,,Interpreting limits to nanoparticle delivery in high-stroma low-perfusion tumors,"RUSSELL, STEWART",DARTMOUTH COLLEGE,NH,"$81,000"
Pancreatic Cancer,2017,NCI,5R01CA207643-02,,Real-time monitoring of circulating pancreatic tumor cells and clusters,"CARPENTER, ERICA",UNIVERSITY OF PENNSYLVANIA,PA,"$522,167"
Pancreatic Cancer,2017,NCI,5R01CA200007-03,,Multiplexed imaging of biliary intra-epithelial neoplasia,"SEIBEL, ERIC",UNIVERSITY OF WASHINGTON,WA,"$569,599"
Pancreatic Cancer,2017,NIAMS,2R01AR060209-06A1,,FoxO signaling and skeletal muscle atrophy,"JUDGE, ANDREW",UNIVERSITY OF FLORIDA,FL,"$397,595"
Pancreatic Cancer,2017,NCI,5F30CA210587-02,,Mechanism behind CCL21/CCR7-mediated pancreatic cancer progression,"MOUSSOURAS, NATASHA",MEDICAL COLLEGE OF WISCONSIN,WI,"$46,044"
Pancreatic Cancer,2017,NIBIB,5F31EB022414-02,,In-vivo characterization of pancreatic field carcinogenesis using spatially resolved reflectance measurements via a fiber optic probe,"ESHEIN, ADAM",NORTHWESTERN UNIVERSITY,IL,"$38,012"
Pancreatic Cancer,2017,NCI,7R01CA178627-04,,Novel Experimental Therapeutics for Pancreatic Cancer,"LOMBERK, GWEN",MEDICAL COLLEGE OF WISCONSIN,WI,"$319,550"
Pancreatic Cancer,2017,NCI,5R21CA209536-02,,Targeting cytokine mediated CREB activation in pancreatic cancer,"NAGATHIHALLI, NAGARAJ",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$166,931"
Pancreatic Cancer,2017,NCI,5R01CA151588-07,,"Mechanisms of Pancreatic Inflammation, Tissue Repair and Carcinogenesis","PASCA DI MAGLIANO, MARINA",UNIVERSITY OF MICHIGAN,MI,"$342,662"
Pancreatic Cancer,2017,NCI,1R01CA208335-01A1,,"Label free microfluidic isolation, characterization and ex vivo expansion of CTCs","NAGRATH, SUNITHA",UNIVERSITY OF MICHIGAN,MI,"$554,517"
Pancreatic Cancer,2017,NIDDK,1R01DK110361-01A1,,The Hippo signaling pathway in pancreatic epithelial cells orchestrate the inflammatory response  R01,"WANG, PEI",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$339,581"
Pancreatic Cancer,2017,NCI,1R01CA208401-01A1,,Protein and proteolytic activity biomarkers of early stage pancreatic cancer,"TEMPST, PAUL",SLOAN-KETTERING INST CAN RESEARCH,NY,"$642,526"
Pancreatic Cancer,2017,NCI,1R01CA208108-01A1,,MUC16 in Pancreatic Cancer Progression and Metastasis,"RADHAKRISHNAN, PRAKASH",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$345,965"
Pancreatic Cancer,2017,NCI,5R01CA042978-31,,Biological Activity of Ras Oncogenes,"DER, CHANNING",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$349,678"
Pancreatic Cancer,2017,NCI,5F31CA196329-02,,Tumor-associated Physiological Changes Arising from Ras-induced Mitochondrial Fission,"NASCIMENTO, ALDO",UNIVERSITY OF VIRGINIA,VA,"$31,376"
Pancreatic Cancer,2017,NCI,5U01CA198913-03,,Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy,"YANG, LILY",EMORY UNIVERSITY,GA,"$595,122"
Pancreatic Cancer,2017,NCI,5K08CA201581-02,,Role of Interleukin-22 and Innate Lymphoid Cells in Pancreas Cancer Initiation and Progression,"FRANKEL, TIMOTHY",UNIVERSITY OF MICHIGAN,MI,"$106,110"
Pancreatic Cancer,2017,NCI,1U01CA216449-01,,Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response,"LAWRENCE, THEODORE",UNIVERSITY OF MICHIGAN,MI,"$578,379"
Pancreatic Cancer,2017,NCI,5U01CA210171-02,,Circulating Biomarker Consortium for Pancreatic Cancer Early Detection,"WOLPIN, BRIAN",DANA-FARBER CANCER INST,MA,"$794,139"
Pancreatic Cancer,2017,NCI,5R01CA104125-13,,Cytoskeletal Dynamics in Pancreatic Cancer Metastasis,"MC NIVEN, MARK",MAYO CLINIC ROCHESTER,MN,"$299,389"
Pancreatic Cancer,2017,NCI,5K08CA172676-05,,Exploration of a Mutant p53 Reactivating Compound,"CARPIZO, DARREN",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$158,958"
Pancreatic Cancer,2017,NCI,5R01CA195733-03,,Employing mouse models to translate early detection of pancreas cancer,"KALLURI, RAGHU",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$540,000"
Pancreatic Cancer,2017,NCI,5P50CA127003-10,7437,"Administration, Evaluation, and Planning","FUCHS, CHARLES",DANA-FARBER CANCER INST,MA,"$190,670"
Pancreatic Cancer,2017,NCI,5U01CA210138-02,,Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer,"PETERSEN, GLORIA",MAYO CLINIC ROCHESTER,MN,"$898,049"
Pancreatic Cancer,2017,NCI,1R01CA207031-01A1,,The molecular mechanisms of metabolism reprogramming in mutant Kras/Ink4a-driven pancreatic ductal adenocarcinoma,"CHIAO, PAUL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$366,000"
Pancreatic Cancer,2017,NCI,5R01CA209886-02,,MRI-Guided Dendritic-Cell-Based Vaccine Immunotherapy for Pancreatic Cancer,"ZHANG, ZHUOLI",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$352,556"
Pancreatic Cancer,2017,NCI,5U01CA210170-02,,Using markers to improve pancreatic cancer screening and surveillance,"GOGGINS, MICHAEL",JOHNS HOPKINS UNIVERSITY,MD,"$953,081"
Pancreatic Cancer,2017,NCI,5R01CA206069-02,,Development of Targeted Nanotechnology Platform for Pancreatic Cancer,"CHAUHAN, SUBHASH",UNIVERSITY OF TENNESSEE HEALTH SCI CTR,TN,"$347,700"
Pancreatic Cancer,2017,NCI,5K22CA178309-03,,Parental Exposure to High Fats Diets and Risk of Pancreatic Cancer in the Offspri,"DE ASSIS, SONIA",GEORGETOWN UNIVERSITY,DC,"$153,035"
Pancreatic Cancer,2017,NCI,5R35CA197591-03,,Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis,"ATTARDI, LAURA",STANFORD UNIVERSITY,CA,"$975,963"
Pancreatic Cancer,2017,NCI,5U01CA199235-03,,Identification of synthetic lethal interactors in pancreatic cancer,"DER, CHANNING",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$340,086"
Pancreatic Cancer,2017,NCI,5F32CA210421-02,,Understanding cell intrinsic and context dependent metabolic adaptations of cancer cell,"DANAI, LAURA",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$56,694"
Pancreatic Cancer,2017,NCI,1R01CA216853-01,,"Metabolic Regulation of Tumor Progression, Metastasis and Chemoresistance by SIRT5/ELK3 signaling in Pancreatic Cancer","SINGH, PANKAJ",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$478,728"
Pancreatic Cancer,2017,NCI,5P30CA036727-31,5713,Planning and Evaluation,"COWAN, KENNETH",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$25,585"
Pancreatic Cancer,2017,NCI,5P30CA036727-31,5727,Gastrointestinal Cancer (GIC),"BLACK, JENNIFER",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$68,219"
Pancreatic Cancer,2017,NCI,5R01CA186885-04,,Targeting BET Bromodomain in Pancreatic Cancer,"MUNSHI, HIDAYATULLAH",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$320,588"
Pancreatic Cancer,2017,NCI,5R01CA195651-03,,Clinical Significance of Pancreatic Cancer Differentiation and Dedifferentiation,"XIE, KEPING",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$366,000"
Pancreatic Cancer,2017,NIAAA,5R13AA020691-07,,International Symposium of ALPD and Cirrhosis,"TSUKAMOTO, HIDEKAZU",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$5,000"
Pancreatic Cancer,2017,NIDDK,5K08DK107781-02,,Characterization of the Molecular Determinants of High-Grade Dysplasia in Pancreatic Cancer Precursor Lesions,"WOOD, LAURA",JOHNS HOPKINS UNIVERSITY,MD,"$171,720"
Pancreatic Cancer,2017,NCI,5R44CA174025-03,,Development of Monoclonal Antibodies to Treat Pancreatic Cancer,"SUREBAN, SRIPATHI","COARE BIOTECHNOLOGY, INC.",OK,"$1,094,011"
Pancreatic Cancer,2017,NCI,5R01CA178015-04,,Crucial Microenvironmental Cofactors for Pancreatic Cancer Pathogenesis,"COLLISSON, ERIC","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$295,065"
Pancreatic Cancer,2017,NCI,5P50CA196510-02,8213,Core A: Administrative Core,"HAWKINS, WILLIAM",WASHINGTON UNIVERSITY,MO,"$151,908"
Pancreatic Cancer,2017,NCI,5P50CA196510-02,8214,Core B: Biospecimen Core,"FIELDS, RYAN",WASHINGTON UNIVERSITY,MO,"$300,637"
Pancreatic Cancer,2017,NCI,5P50CA196510-02,8215,Core C: Biostatistical Core,"COLDITZ, GRAHAM",WASHINGTON UNIVERSITY,MO,"$131,003"
Pancreatic Cancer,2017,NCI,5P50CA196510-02,8216,Developmental Research Program,"LOCKHART, ALBERT",WASHINGTON UNIVERSITY,MO,"$84,023"
Pancreatic Cancer,2017,NCI,5P50CA196510-02,8217,Career Enhancement Program,"GILLANDERS, WILLIAM",WASHINGTON UNIVERSITY,MO,"$79,999"
Pancreatic Cancer,2017,NCI,5P50CA196510-02,8218,Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy,"DENARDO, DAVID",WASHINGTON UNIVERSITY,MO,"$338,182"
Pancreatic Cancer,2017,NCI,5P50CA196510-02,8219,Project 2: Clinical Development of the Pancreatic Cancer Drug Conjugate SW v-49,"HAWKINS, WILLIAM",WASHINGTON UNIVERSITY,MO,"$312,611"
Pancreatic Cancer,2017,NCI,5P50CA196510-02,8220,Project 3: Combination inhibition of ERK for pancreatic cancer treatment,"WANG-GILLAM, ANDREA",WASHINGTON UNIVERSITY,MO,"$280,439"
Pancreatic Cancer,2017,NCI,5P50CA196510-02,8221,Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccine,"GILLANDERS, WILLIAM",WASHINGTON UNIVERSITY,MO,"$464,275"
Pancreatic Cancer,2017,NCI,5R33CA206949-02,,Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology,"SPICER, TIMOTHY",SCRIPPS FLORIDA,FL,"$475,865"
Pancreatic Cancer,2017,NCI,5R01CA202762-02,,Pharmacogenomic and circulating tumor cell approach to individualized treatment of pancreatic cancer,"YU, KENNETH",SLOAN-KETTERING INST CAN RESEARCH,NY,"$558,143"
Pancreatic Cancer,2017,NCI,5K22CA181611-03,,Online monitoring and image-guided treatment of chemoresistant micrometastases,"SPRING, BRYAN",NORTHEASTERN UNIVERSITY,MA,"$186,251"
Pancreatic Cancer,2017,NCI,5R01CA188654-03,,MR-HIFU induced drug delivery for pancreatic cancer treatment,"LEE, DONGHOON",UNIVERSITY OF WASHINGTON,WA,"$495,976"
Pancreatic Cancer,2017,NCI,5R01CA077575-18,,Causes & Consequences of Acid pH in Tumors,"GILLIES, ROBERT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$488,755"
Pancreatic Cancer,2017,NCI,5R01CA161112-07,,Overcoming stromal barriers to therapeutics in pancreas cancer,"HINGORANI, SUNIL",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$620,121"
Pancreatic Cancer,2017,NCI,5R35CA197566-02,,Mechanisms governing metastatic dormancy and reactivation,"GIANCOTTI, FILIPPO",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$959,998"
Pancreatic Cancer,2017,NCI,1R01CA216879-01,,Targeted Molecular Imaging of Plectin-1; Bench to bedside and back again,"SUTCLIFFE, JULIE",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$524,668"
Pancreatic Cancer,2017,NCI,5R01CA098468-14,,Improving CPT-11 Efficacy Using Structural and Chemical Biology,"REDINBO, MATTHEW",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$263,899"
Pancreatic Cancer,2017,NCI,5U01CA187508-03,,A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer,"PALMER, JULIE",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$590,572"
Pancreatic Cancer,2017,NIAAA,5R01AA024770-02,,"A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers.","FERRARI, PIETRO",INTERNATIONAL AGENCY FOR RES ON CANCER,FR,"$494,761"
Pancreatic Cancer,2017,NCI,5R21CA208463-02,,(PQ4) Mutations in the histone chaperone DAXX drive pancreatic neuroendocrine tumors not ductal adenocarcinomas,"LOZANO, GUILLERMINA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$174,000"
Pancreatic Cancer,2017,NCI,5R01CA195708-04,,Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.,"AGARWAL, RAJESH",UNIVERSITY OF COLORADO DENVER,CO,"$382,753"
Pancreatic Cancer,2017,NCI,5R01CA198096-03,,Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium,"STRAUBINGER, ROBERT",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$429,377"
Pancreatic Cancer,2017,NCI,1F31CA217070-01,,Role of the hexosamine biosynthesis pathway in pancreatic cancer.,"CAMPBELL, SYDNEY",UNIVERSITY OF PENNSYLVANIA,PA,"$44,044"
Pancreatic Cancer,2017,NCI,5R01CA182076-04,,Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas,"ALLEN, PETER",SLOAN-KETTERING INST CAN RESEARCH,NY,"$349,513"
Pancreatic Cancer,2017,NCI,5R01CA198074-03,,Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer,"ALLEN, BENJAMIN",UNIVERSITY OF MICHIGAN,MI,"$378,171"
Pancreatic Cancer,2017,NCI,1F30CA216998-01,,The Role of ITIH5 in Suppressing Pancreatic Cancer Metastasis,"YOUNG, ERIC",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$29,244"
Pancreatic Cancer,2017,NCI,1F32CA213795-01A1,,Targeting hyaluronan in the tumor microenvironment to improve DNA vaccine immunotherapy,"DUPERRET, ELIZABETH",WISTAR INSTITUTE,PA,"$56,694"
Pancreatic Cancer,2017,NCI,1R01CA211087-01A1,,Noninvasive prediction of tumor response to gemcitabine using MRI,"LIU, GUANSHU",HUGO W. MOSER RES INST KENNEDY KRIEGER,MD,"$374,878"
Pancreatic Cancer,2017,NCI,1F32CA217033-01,,Epigenetic therapy for pancreatic cancer,"LIANG, GAOYANG",SALK INSTITUTE FOR BIOLOGICAL STUDIES,CA,"$60,990"
Pancreatic Cancer,2017,NCI,5R01CA135274-10,,Overcoming pancreatic tumor resistance to gemcitabine,"CUI, ZHENGRONG","UNIVERSITY OF TEXAS, AUSTIN",TX,"$310,970"
Pancreatic Cancer,2017,NCI,5R01CA168712-04,,Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer,"KELLY, KIMBERLY",UNIVERSITY OF VIRGINIA,VA,"$489,556"
Pancreatic Cancer,2017,NCI,5P50CA102701-14,8353,NFAT Transcription Factors as Therapeutic Targets in Pancreatic Cancer,"BILLADEAU, DANIEL",MAYO CLINIC ROCHESTER,MN,"$267,478"
Pancreatic Cancer,2017,NCI,5P50CA102701-14,8354,Targeting NAD Catabolism in Pancreatic Cancer Cells: Role of Small Molecule SIRT,"CHINI, EDUARDO",MAYO CLINIC ROCHESTER,MN,"$289,095"
Pancreatic Cancer,2017,NCI,5P50CA102701-14,8355,Optimal Pairing of Chemotherapy with Immunotherapy for Pancreatic Cancer,"COHEN, PETER",MAYO CLINIC ROCHESTER,MN,"$387,183"
Pancreatic Cancer,2017,NCI,5P50CA102701-14,8356,Targeting DNA Repair in Selected Patients with Pancreatic Cancer: An Approach to,"COUCH, FERGUS",MAYO CLINIC ROCHESTER,MN,"$269,931"
Pancreatic Cancer,2017,NCI,5P50CA102701-14,8357,Administrative Core,"PETERSEN, GLORIA",MAYO CLINIC ROCHESTER,MN,"$189,674"
Pancreatic Cancer,2017,NCI,5P50CA102701-14,8358,Biostatistics Core,"OBERG, ANN",MAYO CLINIC ROCHESTER,MN,"$267,472"
Pancreatic Cancer,2017,NCI,5P50CA102701-14,8359,Clinical Research Core,"PETERSEN, GLORIA",MAYO CLINIC ROCHESTER,MN,"$238,658"
Pancreatic Cancer,2017,NCI,5P50CA102701-14,8360,Tissue Core,"SMYRK, THOMAS",MAYO CLINIC ROCHESTER,MN,"$160,112"
Pancreatic Cancer,2017,NCI,5P50CA102701-14,8361,Developmental Research Program,"FERNANDEZ-ZAPICO, MARTIN",MAYO CLINIC ROCHESTER,MN,"$118,454"
Pancreatic Cancer,2017,NCI,5P50CA102701-14,8362,Career Developmental Program,"MUKHOPADHYAY, DEBABRATA",MAYO CLINIC ROCHESTER,MN,"$111,943"
Pancreatic Cancer,2017,NCI,5R01CA164964-04,,Prospective Study of Human Oral Microbiome and Pancreatic Cancer Risk,"AHN, JIYOUNG",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$468,512"
Pancreatic Cancer,2017,NCI,5P20CA192996-03,5664,Administrative Core,"MCCOMBIE, WILLIAM",COLD SPRING HARBOR LABORATORY,NY,"$19,351"
Pancreatic Cancer,2017,NCI,5P20CA192996-03,5666,Pilot 2: Organoids to investigate Pancreatic Cancer in under represented minorities,"TUVESON, DAVID",COLD SPRING HARBOR LABORATORY,NY,"$58,786"
Pancreatic Cancer,2017,NCI,5P20CA192994-03,5669,Administrative Core,"LI, ELLEN",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$125,667"
Pancreatic Cancer,2017,NCI,5P20CA192994-03,5671,Pilot Project Research Project 2,"LI, ELLEN",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$93,568"
Pancreatic Cancer,2017,NCI,5U01CA202241-03,,ECM geometrical and mechanical properties modulate RTK signaling,"GROVES, JAY",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$756,191"
Pancreatic Cancer,2017,NCI,1R01CA210637-01A1,,Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia,"PONNUSAMY, MOORTHY",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$373,823"
Pancreatic Cancer,2017,NCI,5F32CA210396-02,,Development of 18F-based Pretargeted PET imaging strategies for the PET imaging of cancer,"MEYER, JAN-PHILIP",SLOAN-KETTERING INST CAN RESEARCH,NY,"$57,066"
Pancreatic Cancer,2017,NCI,5R01CA207110-02,,Prospective immune profiling using methylation markers and pancreatic cancer risk,"MICHAUD, DOMINIQUE",TUFTS UNIVERSITY BOSTON,MA,"$804,995"
Pancreatic Cancer,2017,NCI,5R01CA195473-03,,Repurposing Disulfiram:  A Novel Strategy to Help Cancer Patients Regain Muscle,"JATOI, AMINAH",MAYO CLINIC ROCHESTER,MN,"$466,544"
Pancreatic Cancer,2017,NCI,1R01CA217207-01,,The Development And Progression Of IPMN To PDA In The Context Of Inactivated Activin Signaling,"SU, GLORIA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$454,195"
Pancreatic Cancer,2017,NCI,5R01CA182495-04,,Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures,"KLEMKE, RICHARD",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$376,399"
Pancreatic Cancer,2017,NCI,5R01CA208517-02,,Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds,"PETERSEN, GLORIA",MAYO CLINIC ROCHESTER,MN,"$590,577"
Pancreatic Cancer,2017,NCI,5U54CA210190-02,5200,Core 2: Cell and Whole Animal Genome Engineering,"LARGAESPADA, DAVID",UNIVERSITY OF MINNESOTA,MN,"$62,538"
Pancreatic Cancer,2017,NCI,5U54CA210190-02,5201,Project 1: Physical modeling and dynamics of tumor cell migration mechanics,"ODDE, DAVID",UNIVERSITY OF MINNESOTA,MN,"$551,240"
Pancreatic Cancer,2017,NCI,5U01CA196403-03,,Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas,"MAITRA, ANIRBAN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$787,123"
Pancreatic Cancer,2017,NCI,5U01CA198846-03,,UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer,"NEL, ANDRE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$476,683"
Pancreatic Cancer,2017,NCI,5R01CA193650-03,,The adaptive kinome in pancreatic cancer,"YEH, JEN JEN",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$593,093"
Pancreatic Cancer,2017,NCI,5R01CA187678-04,,PET Imaging-guided Personalized Therapy in Pancreatic Cancer,"RADU, CAIUS",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$585,018"
Pancreatic Cancer,2017,NCI,5R01CA190092-04,,(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer,"TUVESON, DAVID",COLD SPRING HARBOR LABORATORY,NY,"$552,684"
Pancreatic Cancer,2017,NCI,5R01CA199064-02,,Tumor subtypes and therapy response in pancreatic cancer,"YEH, JEN JEN",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$600,010"
Pancreatic Cancer,2017,NCI,5R01CA199646-02,,Optimizing Ultrasound Enhanced Delivery of Therapeutics,"FORSBERG, FLEMMING",THOMAS JEFFERSON UNIVERSITY,PA,"$624,449"
Pancreatic Cancer,2017,NCI,5R01CA183459-04,,Targeting Mucin and EGFR Axis in Pancreatic Cancer,"BATRA, SURINDER",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$311,659"
Pancreatic Cancer,2017,NCI,5R01CA188464-04,,Epigenetic priming in pancreatic cancer chemotherapy,"GOVINDARAJAN, RAJGOPAL",OHIO STATE UNIVERSITY,OH,"$319,550"
Pancreatic Cancer,2017,NIDDK,5K01DK098285-05,,Resolving the role of nicotine-mediated phosphorylation on pancreatic fibrosis,"PAULO, JOAO",HARVARD MEDICAL SCHOOL,MA,"$126,751"
Pancreatic Cancer,2017,NCI,5P50CA174521-03,5336,Project 1: Theranostics in Neuroendocrine Tumors,"MENDA, YUSUF",UNIVERSITY OF IOWA,IA,"$303,328"
Pancreatic Cancer,2017,NCI,5P50CA174521-03,5337,Project 2: Molecular Mechanisms and Biomarkers of Neuroendocrine Tumors,"QUELLE, DAWN",UNIVERSITY OF IOWA,IA,"$300,301"
Pancreatic Cancer,2017,NCI,5P30CA068485-22,7794,Gastrointestinal Cancer Research Program (GI) (Project-005),"BERLIN, JORDAN",VANDERBILT UNIVERSITY,TN,"$87,030"
Pancreatic Cancer,2017,NCI,5R01CA208644-02,,(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.,"CRITTENDEN, MARKA",PROVIDENCE PORTLAND MEDICAL CENTER,OR,"$377,438"
Pancreatic Cancer,2017,NIAAA,5R01AA024698-02,,Alcohol Carcinogenesis,"SRIVASTAVA, RAKESH",LSU HEALTH SCIENCES CENTER,LA,"$328,500"
Pancreatic Cancer,2017,NCI,1R43CA213863-01A1,,A Scalable Blood-based Pancreatic Cancer Test for High-Risk Screening,"FREEDMAN, DAVID","NANOVIEW DIAGNOSTICS, INC.",MA,"$225,001"
Pancreatic Cancer,2017,RMAP,1DP2CA228042-01,,Dissecting tumor metabolic heterogeneity in vivo,"BIRSOY, KIVANC",ROCKEFELLER UNIVERSITY,NY,"$2,542,500"
Pancreatic Cancer,2017,NCI,5R44CA200186-03,,Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer,"HUMBLET, VALERIE","COLLAGEN MEDICAL, LLC",MA,"$1,002,483"
Pancreatic Cancer,2017,NCI,1U54CA217377-01,8362,Biospecimens and Patient-derived xenografts,"WEINSTOCK, DAVID",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$145,250"
Pancreatic Cancer,2017,NCI,1U54CA217377-01,8365,Project 1: Systematic discovery of cell-intrinsic mechanisms of cancer drug resistance,"MANALIS, SCOTT",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$653,390"
Pancreatic Cancer,2017,NCI,1U54CA217377-01,8366,Project 2: 	: Systematic discovery of cell-extrinsic mechanisms of cancer drug resistance,"SHALEK, ALEX",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$614,870"
Pancreatic Cancer,2017,NCI,5U01DK108326-03,,"ALTERED MICROBIOME IN PANCREATITIS, DIABETES AND PANCREATIC CANCER","FISHER, WILLIAM",BAYLOR COLLEGE OF MEDICINE,TX,"$190,000"
Pancreatic Cancer,2017,NIDDK,5U01DK108326-03,,"ALTERED MICROBIOME IN PANCREATITIS, DIABETES AND PANCREATIC CANCER","FISHER, WILLIAM",BAYLOR COLLEGE OF MEDICINE,TX,"$237,950"
Pancreatic Cancer,2017,NCI,5U01DK108288-03,,"The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer","CHARI, SURESH",MAYO CLINIC ROCHESTER,MN,"$190,000"
Pancreatic Cancer,2017,NIDDK,5U01DK108288-03,,"The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer","CHARI, SURESH",MAYO CLINIC ROCHESTER,MN,"$239,300"
Pancreatic Cancer,2017,NCI,5U01DK108306-03,,Consortium for the Study of Pancreatitis: Pittsburgh Clinical Center,"YADAV, DHIRAJ",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$190,000"
Pancreatic Cancer,2017,NIDDK,5U01DK108306-03,,Consortium for the Study of Pancreatitis: Pittsburgh Clinical Center,"YADAV, DHIRAJ",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$218,242"
Pancreatic Cancer,2017,NCI,5U01DK108328-03,,"Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)","FENG, ZIDING",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$400,000"
Pancreatic Cancer,2017,NIDDK,5U01DK108328-03,,"Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)","FENG, ZIDING",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$1,152,014"
Pancreatic Cancer,2017,NCI,5U01DK108314-03,,"Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes","PANDOL, STEPHEN",CEDARS-SINAI MEDICAL CENTER,CA,"$190,000"
Pancreatic Cancer,2017,NIDDK,5U01DK108314-03,,"Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes","PANDOL, STEPHEN",CEDARS-SINAI MEDICAL CENTER,CA,"$255,753"
Pancreatic Cancer,2017,NCI,5U01DK108323-03,,Indiana University (IU) Clinical Center for Chronic Pancreatitis Clinical Research Network,"FOGEL, EVAN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$190,000"
Pancreatic Cancer,2017,NIDDK,5U01DK108323-03,,Indiana University (IU) Clinical Center for Chronic Pancreatitis Clinical Research Network,"FOGEL, EVAN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$231,253"
Pancreatic Cancer,2017,NCI,5U01DK108300-03,,"A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer","PARK, WALTER",STANFORD UNIVERSITY,CA,"$190,000"
Pancreatic Cancer,2017,NIDDK,5U01DK108300-03,,"A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer","PARK, WALTER",STANFORD UNIVERSITY,CA,"$214,605"
Pancreatic Cancer,2017,NCI,5U01DK108320-03,,"U01-Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers","FORSMARK, CHRISTOPHER",UNIVERSITY OF FLORIDA,FL,"$190,000"
Pancreatic Cancer,2017,NIDDK,5U01DK108320-03,,"U01-Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers","FORSMARK, CHRISTOPHER",UNIVERSITY OF FLORIDA,FL,"$198,805"
Pancreatic Cancer,2017,NCI,5U01DK108327-03,,The Ohio State University Pancreatic Disorders Network (OSU-PDN),"CONWELL, DARWIN",OHIO STATE UNIVERSITY,OH,"$190,000"
Pancreatic Cancer,2017,NIDDK,5U01DK108327-03,,The Ohio State University Pancreatic Disorders Network (OSU-PDN),"CONWELL, DARWIN",OHIO STATE UNIVERSITY,OH,"$252,874"
Pancreatic Cancer,2017,NCI,5U01DK108332-03,,"Chronic Pancreatitis, Diabetes and Pancreatic Cancer: A Prospective Approach","VAN DEN EEDEN, STEPHEN",KAISER FOUNDATION RESEARCH INSTITUTE,CA,"$190,000"
Pancreatic Cancer,2017,NIDDK,5U01DK108332-03,,"Chronic Pancreatitis, Diabetes and Pancreatic Cancer: A Prospective Approach","VAN DEN EEDEN, STEPHEN",KAISER FOUNDATION RESEARCH INSTITUTE,CA,"$209,658"
Pancreatic Cancer,2017,NCI,5U24CA210986-02,,Center of Excellence for High Throughput Proteogenomic Characterization,"CARR, STEVEN","BROAD INSTITUTE, INC.",MA,"$1,288,045"
Pancreatic Cancer,2017,NIDDK,5K08DK105326-03,,The Role of NR5A2 in Pancreas Development and Disease,"NISSIM, SAHAR",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$170,640"
Pancreatic Cancer,2017,NHGRI,5R21HG009010-02,,An Integrated Microfluidics Platform for Rapid and Sensitive Exosome RNA,"CHANG, HSUEH-CHIA",UNIVERSITY OF NOTRE DAME,IN,"$193,125"
Pancreatic Cancer,2017,NCI,5R50CA211506-02,,Preclinical Models for Cancer Therapeutic Development,"PARK, YOUNGKYU",COLD SPRING HARBOR LABORATORY,NY,"$174,117"
Pancreatic Cancer,2017,NIBIB,5R01EB020125-03,,Theranostic nanoparticles for detection and treatment of pancreatic cancer,"MCNALLY, LACEY",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$74,421"
Pancreatic Cancer,2017,NIGMS,5R01EB020125-03,,Theranostic nanoparticles for detection and treatment of pancreatic cancer,"MCNALLY, LACEY",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$320,000"
Pancreatic Cancer,2017,NCI,5R50CA211462-02,,Critical resources provided by UNMC RAP biorepository stimulate cancer research,"GRANDGENETT, PAUL",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$106,754"
Pancreatic Cancer,2017,NCI,5R50CA211437-02,,Revealing cancer metabolism via mass spectrometry and isotope tracers,"LU, WENYUN",PRINCETON UNIVERSITY,NJ,"$108,427"
Pancreatic Cancer,2017,NIAMS,5R21AR071021-02,,Modeling muscle wasting in cancer cachexia,"GUTTRIDGE, DENIS",OHIO STATE UNIVERSITY,OH,"$169,400"
Pancreatic Cancer,2017,NIDDK,5R01DK060694-16,,Networks for functional regulation of pancreatic acinar-ductal metaplasia and epithelial plasticity,"RUSTGI, ANIL",UNIVERSITY OF PENNSYLVANIA,PA,"$362,250"
Pancreatic Cancer,2017,NCI,7R01CA188048-03,,Investigating a novel glutamine metabolism pathway in pancreatic cancer,"KIMMELMAN, ALEC",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$333,525"
Pancreatic Cancer,2017,NCI,5F31CA210627-02,,Functional Interrogation of Kdm6a-Dependent Tumor Suppression during Pancreatic Cancer,"WINTERS, IAN",STANFORD UNIVERSITY,CA,"$35,431"
Pancreatic Cancer,2017,NCI,1U01CA217665-01,,Peptide-based targeted molecular imaging for early detection in pancreatic cancer,"SUTCLIFFE, JULIE",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$650,375"
Pancreatic Cancer,2017,NCI,5R21CA209366-02,,Identifying insulin resistance biomarkers and metabolomic signature as predictors of precursors to pancreatic cancer,"ZHANG, JIANJUN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$171,281"
Pancreatic Cancer,2017,NIBIB,1P41EB024495-01,5626,Imaging Agents for Inflammatory Components of Malignancy,"POMPER, MARTIN",JOHNS HOPKINS UNIVERSITY,MD,"$259,734"
Pancreatic Cancer,2017,NCI,5P01CA117969-12,8397,Core A: Pathology Core,"MAITRA, ANIRBAN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$89,149"
Pancreatic Cancer,2017,NCI,5P01CA117969-12,8398,Core B: Preclinical Therapeutics Core,"BENES, CYRIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$96,117"
Pancreatic Cancer,2017,NCI,5P01CA117969-12,8399,Core C: Computational Core,"FUTREAL, ANDREW",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$73,621"
Pancreatic Cancer,2017,NCI,5P01CA117969-12,8400,Core D: Administrative Core,"DEPINHO, RONALD",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$31,509"
Pancreatic Cancer,2017,NCI,5P01CA117969-12,8401,Project 1: Targeting Metabolic Dependencies in PDAC,"DEPINHO, RONALD",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$227,876"
Pancreatic Cancer,2017,NCI,5P01CA117969-12,8402,Project 2: Role of lysosomal scavenging in PDAC metabolism,"BARDEESY, NABEEL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$292,025"
Pancreatic Cancer,2017,NCI,5P01CA117969-12,8403,Project 3: The Functional Contribution of Tumor Immunity in PDAC,"KALLURI, RAGHU",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$183,081"
Pancreatic Cancer,2017,NCI,5P01CA203657-02,8379,Project 1: Mutation-specific vulnerabilities for KRAS-targeted therapy,"DER, CHANNING",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$124,398"
Pancreatic Cancer,2017,NCI,5P01CA203657-02,8381,Project 3: Mechanisms and therapeutic targeting of NRAS in melanoma,"COX, ADRIENNE",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$144,071"
Pancreatic Cancer,2017,NCI,1U01CA217842-01,,Integrative bioinformatics and functional characterization of oncogenic driver aberrations in cancer,"MILLS, GORDON",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$739,551"
Pancreatic Cancer,2017,NCI,3R01CA186043-03S1,,Musashi-mediated control of pancreatic cancer growth and progression,"REYA, TANNISHTHA",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$53,663"
Pancreatic Cancer,2017,NCI,5U54CA210181-02,5158,Administrative Core,"FERRARI, MAURO",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$486,539"
Pancreatic Cancer,2017,NCI,5U54CA210181-02,5159,Transport Oncophysics Core,"FERRARI, MAURO",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$447,272"
Pancreatic Cancer,2017,NCI,5U54CA210181-02,5161,Microenvironmental Transport for Immunotherapy in Pancreatic Cancer,"FLEMING, JASON",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$234,409"
Pancreatic Cancer,2017,NCI,5P30CA013330-45,6910,Experimental Therapeutics,"GOLDMAN, ISRAEL",ALBERT EINSTEIN COLLEGE OF MEDICINE,NY,"$315,258"
Pancreatic Cancer,2017,NCI,5P30CA015704-42,5445,Research Program: Gastrointestinal Cancer,"GRADY, WILLIAM",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$118,761"
Pancreatic Cancer,2017,NCI,5P50CA127297-09,5480,Inhibition of CDK5 as a Treatment for Pancreatic Cancer,"HOLLINGSWORTH, MICHAEL",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$379,900"
Pancreatic Cancer,2017,NCI,5P50CA127297-09,5481,Novel Target(s) in the Radiosensitization of Pancreatic Cancer,"BATRA, SURINDER",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$378,716"
Pancreatic Cancer,2017,NCI,5P50CA127297-09,5482,Novel Strategies for Pancreatic Cancer Treatment,"BLACK, JENNIFER",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$379,899"
Pancreatic Cancer,2017,NCI,5P50CA127297-09,5483,Targeting Metabolic Alterations to Improve Survival in Pancreatic Cancer,"SINGH, PANKAJ",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$379,895"
Pancreatic Cancer,2017,NCI,5P50CA127297-09,5484,Administrative Core,"HOLLINGSWORTH, MICHAEL",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$260,600"
Pancreatic Cancer,2017,NCI,5P50CA127297-09,5485,Tissue Core,"BRIDGE, JULIA",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$279,029"
Pancreatic Cancer,2017,NCI,5P50CA127297-09,5486,Biostatistics,"YU, FANG",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$82,856"
Pancreatic Cancer,2017,NCI,5P50CA127297-09,5487,Developmental Research Program,"HOLLINGSWORTH, MICHAEL",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$98,730"
Pancreatic Cancer,2017,NCI,5P50CA127297-09,5488,Career Development Program,"HOLLINGSWORTH, MICHAEL",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$139,758"
Pancreatic Cancer,2017,NCI,1K08CA218690-01,,Defining diverse roles of p53 in pancreatic cancer,"KIM, MICHAEL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$170,640"
Pancreatic Cancer,2017,NCI,1R21CA205660-01A1,,Improving the radiation therapeutic ratio by inhibiting proinflammatory cytokines,"KIM, JAE HO",HENRY FORD HEALTH SYSTEM,MI,"$195,859"
Pancreatic Cancer,2017,NCI,1K08CA218420-01,,Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer,"AGUIRRE, ANDREW",DANA-FARBER CANCER INST,MA,"$177,120"
Pancreatic Cancer,2017,NCI,1R21CA218495-01,,Inhibition of Stromal-Derived DKK3 to Enhance the Response of Pancreatic Cancer to Immunotherapy,"HWANG, ROSA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$208,800"
Pancreatic Cancer,2017,NCI,1U01CA213862-01A1,,Nanovaccine platforms to combat pancreatic cancer,"NARASIMHAN, BALAJI",IOWA STATE UNIVERSITY,IA,"$566,261"
Pancreatic Cancer,2017,NCI,1R01CA218513-01,,Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model,"LYDEN, DAVID",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$472,052"
Pancreatic Cancer,2017,NCI,1R21CA218968-01,,Novel model to study PDAC using normal human pancreatic tissue,"WANG, PEI",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$199,013"
Pancreatic Cancer,2017,NCI,1R03CA201738-01A1,,Role of CRABP-II in pancreatic cancer metastasis,"YU, SHUILIANG",CASE WESTERN RESERVE UNIVERSITY,OH,"$80,000"
Pancreatic Cancer,2017,NCI,1R01CA211070-01A1,,The Pancreatic Cancer Microenvironment,"KANG, RUI",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$325,020"
Pancreatic Cancer,2017,NCI,3R01CA075059-19S1,,Dysregulation of TGF Beta Action Pancreatic Cancer,"KORC, MURRAY",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$49,543"
Pancreatic Cancer,2017,NCI,3R01CA175772-04S1,,Targeting tumor-stromal interaction for pancreatic cancer therapy,"SINGH, AJAY",UNIVERSITY OF SOUTH ALABAMA,AL,"$158,135"
Pancreatic Cancer,2017,NCI,3R01CA181385-04S1,,Stellate cells and their progenitor precursors in pancreas cancer progression,"PROVENZANO, PAOLO",UNIVERSITY OF MINNESOTA,MN,"$102,872"
Pancreatic Cancer,2017,NCI,3R01CA186885-04S1,,Targeting BET Bromodomain in Pancreatic Cancer,"MUNSHI, HIDAYATULLAH",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$116,835"
Pancreatic Cancer,2017,NCI,3P20CA192994-03S1,,1/2: Partnership to study racial/ethnic differences in GI cancer biology,"LI, ELLEN",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$63,140"
Pancreatic Cancer,2017,NCI,1R01CA211098-01A1,,Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease,"FLICK, MATTHEW",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$431,066"
Pancreatic Cancer,2017,NCI,4R00CA188259-03,,Regulation of cancer cell metabolism and growth by the pancreatic tumor stroma,"SHERMAN, MARA",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$249,000"
Pancreatic Cancer,2017,NCI,1R01CA220236-01,,Wnt/?-catenin Signaling in Pancreatic Oncogenesis,"XIE, KEPING",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$366,000"
Pancreatic Cancer,2017,NCI,1R21CA213114-01A1,,Reprogramming Tumor-Associated Macrophages in PDAC with MicroRNA Nano-Vectors,"AMIJI, MANSOOR",NORTHEASTERN UNIVERSITY,MA,"$170,738"
Pancreatic Cancer,2017,NIGMS,1R35GM124958-01,,Chromatin Dynamics and Genome Regulation,"BANASZYNSKI, LAURA",UT SOUTHWESTERN MEDICAL CENTER,TX,"$405,000"
Pancreatic Cancer,2017,NCI,2R01CA155620-06A1,,RON Receptor in Pancreatic Cancer Biology and Therapy,"LOWY, ANDREW",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$306,943"
Pancreatic Cancer,2017,NCI,1R01CA212086-01A1,,Optimizing the Treatment of Pancreatic Adenocarcinoma,"HUR, CHIN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$398,519"
Pancreatic Cancer,2017,NCI,3R01CA200755-02S1,,Exploring the Role of Mitochondrial Fission in Pancreatic Tumorigenesis,"KASHATUS, DAVID",UNIVERSITY OF VIRGINIA,VA,"$191,853"
Pancreatic Cancer,2017,NCI,1R01CA211082-01A1,,Optical imaging of pancreas cancer organoids for drug development and personalized treatment,"SKALA, MELISSA","MORGRIDGE INSTITUTE FOR RESEARCH, INC.",WI,"$648,387"
Pancreatic Cancer,2017,NCI,1R35CA209960-01A1,,Molecular Imaging and Theranostics of Cancer,"BHUJWALLA, ZAVER",JOHNS HOPKINS UNIVERSITY,MD,"$691,623"
Pancreatic Cancer,2017,NCI,3R01CA189209-03S1,,Radio-immunotherapy to Target Cancer Stem Cells in Solid Tumor Malignancies,"MURPHY, WILLIAM",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$70,981"
Pancreatic Cancer,2017,NCI,4R00CA197816-03,,The SMYD3-ERK5 signaling module in pancreatic cancer,"MAZUR, PAWEL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$249,000"
Pancreatic Cancer,2017,NCI,1R21CA220625-01,,Targeting hyaluronan synthesis and signaling with BET inhibitors in pancreatic cancer,"KUMAR, KRISHAN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$206,190"
Pancreatic Cancer,2017,NCI,3R01CA151588-07S1,,"Mechanisms of Pancreatic Inflammation, Tissue Repair and Carcinogenesis","PASCA DI MAGLIANO, MARINA",UNIVERSITY OF MICHIGAN,MI,"$72,605"
Pancreatic Cancer,2017,NCI,1F30CA220680-01,,Physiological Role of Dynamin-Related Protein 1 in Pancreatic Ductal Adenocarcinoma,"NAGDAS, SARBAJEET",UNIVERSITY OF VIRGINIA,VA,"$31,485"
Pancreatic Cancer,2017,NCI,1F31CA220750-01,,At the nexus of redox and signaling pathways: regulation of NAD+ kinase,"SCHILD, TANYA",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$44,044"
Pancreatic Cancer,2017,NIDDK,1R13DK114948-01,,2017 Pancreatic Diseases Gordon Research Conference,"SIMEONE, DIANE",GORDON RESEARCH CONFERENCES,RI,"$20,000"
Pancreatic Cancer,2017,NCI,1F32CA221005-01,,Targeting CDK4/6 for pancreatic cancer treatment,"GOODWIN, CRAIG",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$56,694"
Pancreatic Cancer,2017,NCI,1F31CA221066-01,,Examining the Heterogeneity of Fibroblasts in the Pancreatic Microenvironment,"GARCIA, PALOMA",UNIVERSITY OF MICHIGAN,MI,"$31,793"
Pancreatic Cancer,2017,NCI,1F31CA220970-01,,"Image-guided, sonoporation-enhanced immunotherapy for pancreatic cancer treatment","FIX, SAMANTHA",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$35,005"
Pancreatic Cancer,2017,NCI,1F32CA221114-01,,Examination of ceramide signaling in the crosstalk between pancreatic cancer cells and the tumor microenvironment,"HENDLEY, AUDREY","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$56,694"
Pancreatic Cancer,2017,NCI,1F32CA221094-01,,The role of p120ctn in PDAC epithelial-to-mesenchymal transition and metastasis,"PITARRESI, JASON",UNIVERSITY OF PENNSYLVANIA,PA,"$56,334"
Pancreatic Cancer,2017,NCI,1F31CA213731-01A1,,Pathophysiological role and therapeutic potential of microRNA-29 in pancreatic cancer autophagy,"KWON, JASON",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$29,255"
Pancreatic Cancer,2017,NCI,1F31CA220937-01,,The Novel Role of REST in the Development of Pancreatic Ductal Adenocarcinoma,"BRAY, JULIE",UNIVERSITY OF FLORIDA,FL,"$38,743"
Pancreatic Cancer,2017,NCI,1U01CA216468-01A1,,Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches,"LIN, STEVEN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$596,334"
Pancreatic Cancer,2017,NIDDK,1R13DK115223-01,,"PancreasFest 2017 Detection, Assessment and Management of Complex Pancreatic Disorders","WHITCOMB, DAVID",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$10,000"
Pancreatic Cancer,2017,NCI,1R01CA216987-01A1,,K-Ras sumoylation in cell proliferation and transformation,"DAI, WEI",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$514,857"
Pancreatic Cancer,2017,NCI,1R01CA208205-01A1,,Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment,"FUKUMURA, DAI",MASSACHUSETTS GENERAL HOSPITAL,MA,"$495,129"
Pancreatic Cancer,2017,NCI,3F32CA210421-01S1,,Understanding cell intrinsic and context dependent metabolic adaptations of cancer cell,"DANAI, LAURA",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$2,212"
Pancreatic Cancer,2017,NCI,3F32CA200078-01A1S1,,Chemical genetic investigation of metastatic seeding in pancreatic ductal adenocarcinoma using novel multiplexed in vivo screening,"SCHULZE, CHRISTOPHER",STANFORD UNIVERSITY,CA,$316
Pancreatic Cancer,2017,NCI,4R00CA208032-02,,Deciphering the role of Lin28b in pancreatic cancer to guide therapeutic discovery,"KUGEL, SITA",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$249,000"
Pancreatic Cancer,2017,NCI,3F32CA200313-02S1,,K-Ras mutant-specific vulnerabilities for novel pancreatic cancer therapies,"HOBBS, GUY",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,$948
Pancreatic Cancer,2017,NCI,1R43CA221400-01,,Novel monobody therapy for pancreatic cancer,"YU, BO","LARIX BIOSCIENCE, LLC",CA,"$224,981"
Pancreatic Cancer,2017,NCI,1R43CA217400-01A1,,First-in-class TREM-1 inhibitors in combination therapy for pancreatic cancer,"SIGALOV, ALEXANDER","SIGNABLOK, INC.",MA,"$224,672"
Pancreatic Cancer,2017,OD,3R01CA164964-03S1,,Prospective Study of Human Oral Microbiome and Pancreatic Cancer Risk,"AHN, JIYOUNG",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$169,500"
Pancreatic Cancer,2017,NCI,2R44CA183265-02A1,,FrostBite - A Unique Catheter for Endoscopic Cryoablation,"BAUST, J","CELL PRESERVATION SERVICES, INC.",NY,"$1,008,442"
Pancreatic Cancer,2017,NCI,1R41CA217482-01A1,,Development of a protein drug for pancreatic cancer treatment,"LIU, ZHI-REN","PRODA BIOTECH, LLC",GA,"$167,021"
Pancreatic Cancer,2017,NCI,1R43CA210854-01A1,,A highly specific NIRF/PET probe for the detection of cancer and metastases,"YANG, XINLIN","IMOL RADIOPHARMACEUTICALS, LLC",VA,"$224,958"
Pancreatic Cancer,2017,NIDDK,1R44DK117472-01A1,,MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases,"JUNKER, WADE",SANGUINE DIAGNOSTICS AND THERAPEUTICS,NE,"$199,020"
Pancreatic Cancer,2017,NCI,1R43CA217502-01A1,,Oral formulation for novel inhibitor of Ras driven cancers,"CANZONERI, JOSHUA","ADT PHARMACEUTICALS, LLC",AL,"$300,000"
Pancreatic Cancer,2017,NCI,3R43CA200398-01A1S1,,Digital Analysis of Plasma miRNA populations in Pancreatic Cancer,"WEIER, CHRISTOPHER","REDVAULT BIOSCIENCES, LP",TX,"$49,970"
Pancreatic Cancer,2017,NCI,3F32CA210387-01S1,,The role of Prrx1 in acinar-ductal metaplasia during pancreatic tumorigenesis,"COLLINS, MEREDITH",UNIVERSITY OF PENNSYLVANIA,PA,$553
Pancreatic Cancer,2017,NIGMS,5R01GM111735-05,,Phosphatidylinositol 4-Phosphate Hydrolysis in Spatiotemporal Cell Signaling,"SMRCKA, ALAN",UNIVERSITY OF MICHIGAN,MI,"$294,658"
Pancreatic Cancer,2017,NCI,5R01CA188048-04,,Investigating a novel glutamine metabolism pathway in pancreatic cancer,"KIMMELMAN, ALEC",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$387,731"
Pancreatic Cancer,2017,NIBIB,1R01EB025173-01,,Endoscopic Fine-Needle Polarized Scanning Spectroscopy for Pancreatic Cystic Lesions Diagnosis,"PERELMAN, LEV",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$722,453"
Pancreatic Cancer,2017,NCI,1R50CA211425-01A1,,Defining and targeting mechanisms of pancreas cancer pathogenesis,"WHITTLE, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$139,320"
Pancreatic Cancer,2017,NCI,261200800001E-111-0-36,,Repository Services for epidemiology studies,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$1,380,084"
Pancreatic Cancer,2017,NCI,261201500022C-2-0-1,,PHASE III TRIAL OF CARBON ION THERAPY,"GUHA, CHANDAN","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$453,713"
Pancreatic Cancer,2017,NCI,1F99CA223043-01,,Defining the barriers to immune surveillance in solid tumors,"HEGDE, SAMARTH",WASHINGTON UNIVERSITY,MO,"$29,654"
Pancreatic Cancer,2017,NCI,1U24CA224020-01,,Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC),"WISTUBA, IGNACIO",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$1,679,941"
Pancreatic Cancer,2017,NCI,1U54CA224065-01,8591,Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer,"FLEMING, JASON",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$483,810"
Pancreatic Cancer,2017,NCI,1U54CA224083-01,8744,Research Project 2: Development of Synergetic EKR Combinations in PDAC,"WANG-GILLAM, ANDREA",WASHINGTON UNIVERSITY,MO,"$425,714"
Pancreatic Cancer,2017,NCI,1U01CA224145-01,,Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer,"CRAWFORD, HOWARD",UNIVERSITY OF MICHIGAN,MI,"$1,497,616"
Pancreatic Cancer,2017,NCI,1U01CA224146-01,,Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens,"HAHN, WILLIAM",DANA-FARBER CANCER INST,MA,"$1,845,039"
Pancreatic Cancer,2017,NCI,1U01CA224175-01,,Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy,"BALACHANDRAN, VINOD",SLOAN-KETTERING INST CAN RESEARCH,NY,"$1,850,296"
Pancreatic Cancer,2017,NCI,1U01CA224193-01,,Disrupting the immune and drug-privileged microenvironment in pancreas cancer,"HINGORANI, SUNIL",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$1,846,829"
Pancreatic Cancer,2017,NCI,1U01CA224348-01,,Reprogramming PDAC tumor microenvironment to improve immunotherapy,"JAIN, RAKESH",MASSACHUSETTS GENERAL HOSPITAL,MA,"$1,761,342"
Pancreatic Cancer,2017,NCI,3R01CA195708-04S1,,Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.,"AGARWAL, RAJESH",UNIVERSITY OF COLORADO DENVER,CO,"$94,087"
Pancreatic Cancer,2017,NCI,3U01CA200466-02S1,,Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms,"BRAND, RANDALL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$129,694"
Pancreatic Cancer,2017,NCI,1R44CA224460-01,,Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial,"DAUNCH, WILLIAM","ADVANCED CHEMOTHERAPY TECHNOLOGIES, INC.",NC,"$299,805"
Pancreatic Cancer,2017,NCI,1R44CA224994-01,,Ultra-High Content Analysis (UHCA) of Single Cells in Tissue: 60+ channel immunofluorescence labeling kits and companion imaging software for everyone,"NEDERLOF, MICHEL","QUANTITATIVE IMAGING SYSTEMS, LLC",PA,"$224,791"
Pancreatic Cancer,2017,NIDDK,1R43DK115341-01A1,,Development of fluorogenic substrates for the diagnosis of pancreatic cysts,"KNUDSEN, GISELLE","ALAUNUS BIOSCIENCES, INC.",CA,"$235,341"
Pancreatic Cancer,2017,NCI,1F31CA210631-01A1,,Elucidating the Role of Fasting in GI Radioprotection: Applications in Pre-Clinical Pancreatic Cancer Model,"DE LA CRUZ BONILLA, MARIMAR",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$31,036"
Pancreatic Cancer,2017,NCI,1R43CA225169-01,,Endoscopic Flexible Pancreatic Tumor Ablation System with Reduced Force Effector and Specialized Ablation Zone,"SNOOK, KEVIN","ACTUATED MEDICAL, INC.",PA,"$295,205"
Pancreatic Cancer,2017,NCI,1R33CA225248-01,,Area A: In-Depth Proteome Mapping of the Tumor Microenvironment with Single-Cell Resolution,"KELLY, RYAN",BATTELLE PACIFIC NORTHWEST LABORATORIES,WA,"$1,744,991"
Pancreatic Cancer,2017,NCI,1R33CA225380-01,,Molecular Beacon Based Extracellular mRNA and Protein Detection for Early Cancer Diagnosis,"LEE, LY",OHIO STATE UNIVERSITY,OH,"$1,588,359"
Pancreatic Cancer,2017,NCI,4R00CA190889-03,,Integrative Analyses to Identify Pancreatic Cancer Susceptibility Genes,"ROBERTS, NICHOLAS",JOHNS HOPKINS UNIVERSITY,MD,"$249,000"
Pancreatic Cancer,2017,NCI,3U01CA198913-03S1,,Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy,"YANG, LILY",EMORY UNIVERSITY,GA,"$56,018"
Pancreatic Cancer,2017,NCI,3R01CA170911-07S1,,Deciphering  the Tissue Specificity of MEN1 Related Tumorigenesis,"LIBUTTI, STEVEN",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$45,916"
Pancreatic Cancer,2017,NCI,3U01CA128454-10S1,,Discovery and Development of Cancer Glycomarkers,"PIERCE, J.",UNIVERSITY OF GEORGIA,GA,"$103,236"
Pancreatic Cancer,2017,NCI,1ZIACP010120-22,,Studies of Occupational Cancer,"LAN, QING",NIH,,"$2,973,053"
Pancreatic Cancer,2017,NCI,1ZIACP010131-22,,Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,"BERRINGTON DE GONZALEZ, AMY",NIH,,"$4,206,471"
Pancreatic Cancer,2017,NCI,1ZIACP010136-22,,Cancer Risk in Human Populations,"SILVERMAN, DEBRA",NIH,,"$2,956,825"
Pancreatic Cancer,2017,NCI,1ZIACP010184-15,,Consultation and Collaboration,"GRAUBARD, BARRY",NIH,,"$910,442"
Pancreatic Cancer,2017,NCI,1ZIACP010193-11,,Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan),"SOLOMON, RACHAEL",NIH,,"$229,953"
Pancreatic Cancer,2017,NCI,1ZIACP010202-09,,"Biochemical, molecular, and dietary studies for pancreatic cancer within PLCO","SOLOMON, RACHAEL",NIH,,"$84,531"
Pancreatic Cancer,2017,NIDDK,1ZIADK047051-11,,Studies of  clinical endocrine tumors,"GORDEN, PHILLIP",NIH,,"$263,476"
Pancreatic Cancer,2017,NICHD,1ZIAHD008804-11,,The Role of Carboxypeptidase E in Cancer,"LOH, YOKE PENG",NIH,,"$428,245"
Pancreatic Cancer,2017,NCATS,1ZIATR000019-03,,Studies of Tumor-Penetrating Microparticles for Pancreatic Cancer Trauma,"XU, XIN",NIH,,"$280,863"
Pancreatic Cancer,2017,NCATS,1ZIATR000278-01,,Metarrestin for the Treatment of Pancreatic Cancer,"XU, XIN",NIH,,"$429,191"
Pancreatic Cancer,2017,NCI,3U01CA196403-03S1,,Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas,"MAITRA, ANIRBAN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$320,000"
Pancreatic Cancer,2017,NIBIB,1R56EB024320-01A1,,Surrogate imaging biomarkers for tracking anti-stromal therapy,"DOYLEY, MARVIN",UNIVERSITY OF ROCHESTER,NY,"$440,024"
Pancreatic Cancer,2017,NIDDK,1ZIADK043006-41,,"Hyperparathyroidism -- Etiology, Diagnosis and Treatment","SIMONDS, WILLIAM",NIH,,"$83,011"
Pancreatic Cancer,2017,NIDDK,1ZIADK075035-09,,Genes associated with endocrine tumorigenesis,"AGARWAL, SUNITA",NIH,,"$362,862"
Pancreatic Cancer,2017,NIDDK,1ZIADK075085-05,,Role of tissue differentiation factors in endocrine tumorigenesis,"AGARWAL, SUNITA",NIH,,"$362,862"
Pancreatic Cancer,2017,NIDDK,1ZIADK053200-26,,"Diagnosis, Natural History, Management,tumor biology  of  Gastrinomas/PETs","JENSEN, ROBERT",NIH,,"$159,091"
Pancreatic Cancer,2017,NCI,ACN15006001-1-0-1,,NCI Early Detection Research Network:  Biomarker Reference and Resource Center (BRRC),NO PI IDENTIFIED,NIH,,"$800,000"
Pancreatic Cancer,2017,NCI,1ZIABC010298-20,,Growth Regulation Section,"PASTAN, IRA",NIH,,"$427,052"
Pancreatic Cancer,2017,NCI,1ZIABC010774-11,,T Cell Alternative p38 Activation Pathway,"ASHWELL, JONATHAN",NIH,,"$778,421"
Pancreatic Cancer,2017,NCI,1ZIABC011162-09,,Integrative Molecular Profiling of Human Pancreatic Cancer,"HUSSAIN, SYED PERWEZ",NIH,,"$705,721"
Pancreatic Cancer,2017,NCI,1ZIABC011185-09,,Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer,"HUSSAIN, SYED PERWEZ",NIH,,"$705,721"
Pancreatic Cancer,2017,NCI,1ZIABC011267-08,,Preclinical drug development in pancreatic cancer,"RUDLOFF, UDO",NIH,,"$1,140,440"
Pancreatic Cancer,2017,NCI,1ZIABC011275-08,,Genomic and genetic studies of endocrine cancers,"KEBEBEW, ELECTRON",NIH,,"$582,719"
Pancreatic Cancer,2017,NCI,1ZIABC011343-08,,Clinical protocols for the treatment of gastrointestinal cancer,"GRETEN, TIM",NIH,,"$215,076"
Pancreatic Cancer,2017,NCI,1ZIABC011485-05,,Forkhead-box (FOX) Transcription Factors in the Progression of Pancreatic Cancer,"HUSSAIN, SYED PERWEZ",NIH,,"$156,826"
Pancreatic Cancer,2017,NCI,1ZIABC011652-03,,Mesothelin-targeted immunotoxins in Pancreatic Cancer,"ALEWINE, CHRISTINE",NIH,,"$924,682"
Pancreatic Cancer,2017,NCI,1ZIABC011739-02,,Development and Preclinical Application of Pancreatic Adenocarcinoma Models,"SHARAN, SHYAM",NIH,,"$1,539,864"
Pancreatic Cancer,2017,NCI,1ZIABC011775-01,,Immune cell control of ovarian cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$430,385"
Pancreatic Cancer,2017,NCI,1ZIASC006353-35,,Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,"BRECHBIEL, MARTIN",NIH,,"$926,927"
Pancreatic Cancer,2017,NCI,1ZIASC010373-17,,The Synergy Between Radiotherapy and Molecularly Targeted Agents,"CAMPHAUSEN, KEVIN",NIH,,"$892,156"
Pancreatic Cancer,2017,NCI,1ZIDBC011540-04,,Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core,"HASSAN, RAFFIT",NIH,,"$1,890,317"
Pancreatic Cancer,2017,NCI,1ZIGBC011735-02,,Development of Novel Preclinical Animal Models - CAPR Infrastructure,"SHARAN, SHYAM",NIH,,"$513,288"
Pancreatic Cancer,2017,NCI,4R44CA210770-02,,"Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Pancreatic Cancers","PEREZ, KRISTY","CIVATECH ONCOLOGY, INC.",NC,"$1,464,585"
Pancreatic Cancer,2017,NCI,3R01CA208205-01A1S1,,Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment,"FUKUMURA, DAI",MASSACHUSETTS GENERAL HOSPITAL,MA,"$162,720"
Pancreatic Cancer,2017,NIAAA,3R01AA024698-02S1,,Alcohol Carcinogenesis,"SRIVASTAVA, RAKESH",LSU HEALTH SCIENCES CENTER,LA,"$51,021"
Pancreatic Cancer,2017,NCI,3R43CA200398-01A1S2,,Digital Analysis of Plasma miRNA populations in Pancreatic Cancer,"WEIER, CHRISTOPHER","REDVAULT BIOSCIENCES, LP",TX,"$50,000"
Pancreatic Cancer,2017,NCI,3U01DK108328-03S1,,"Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)","FENG, ZIDING",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$1,500,000"
Pancreatic Cancer,2017,NCI,261201500037I-0-26100006-1,,EFFECT OF A MULTIPEPTIDE KRAS VACCINE IN THE PREVENTION OF PANCREATIC CANCER DRIVEN BY KRAS ONCOPROTEIN HHSN2612015000371  TORFP: 2017-E02,"YOU, MING",MEDICAL COLLEGE OF WISCONSIN,WI,"$800,994"
Pancreatic Cancer,2017,NCI,7K08CA208016-03,,Elucidating KRAS-specific vulnerabilities in pancreatic cancer,"MUZUMDAR, MANDAR",YALE UNIVERSITY,CT,"$139,563"
Pancreatic Cancer,2017,NCI,261201600005I-0-26100002-1,,"Medical Images for BiospecimensThe Task Order is in the amount of $71,250.00","WIZNEROWICZ, MACIEJ",INTERNAT'L INSTITUTE/MOLECULAR ONCOLOGY,POLAND,"$71,250"
